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The historical notion of a microbial population has been of a clonal population of 
identical swimming planktonic cells in a laboratory flask.  As the field has advanced, 
we have grown to appreciate the immense diversity in microbial behaviors, from 
their propensity to grow in dense surface-attached communities as a biofilm, to the 
consequences of social dilemmas between cells, to their ability to form spores able to 
survive nearly any environmental insult.  However, the historically biased view of 
the clonal microbial population still persists – even when a rare phenotype is 
investigated, the focus simply shifts to that narrower focal population - and this bias 
can lead to some of the broader questions relating to the consequences of phenotypic 
diversity within populations to be overlooked. 
This work seeks to address this gap by investigating the evolutionary causes and 
consequences of phenotypic heterogeneity, with a focus on clinically relevant 
phenotypes.  We first develop and experimentally validate a theoretical model 
describing the evolution of a microbial population faced with a trade-off between 
survival and fecundity phenotypes (e.g. biofilm and planktonic cells), which suggests 
that simultaneous investment in both types maximizes lineage fitness in 
heterogeneous environments.  This model helps to inform the experimental studies 
in the following chapters.  We find that biofilm-mediated phenotypic resistance to 
antibiotics is evolutionarily labile, and responsive to antibiotic dose and whether 
biofilm or planktonic cells are passaged.  We also show that persistence in E. coli is 
age-independent, supporting the current hypothesis of stochastic metabolic 
fluctuations as the cause of this rare phenotype.  Finally, we explore phenotypic 
variation across a library of natural isolates of P. aeruginosa, and find few organizing 
principles among key phenotypes related to virulence.  Together these results suggest 
that phenotypic heterogeneity is a crucial component in the ecology and evolution of 
microbial populations, and directly affects pressing applied concerns such as the 





Historically, scientists have studied bacteria as populations of identical cells, 
swimming freely in rich nutrient broth.  However, more recently it has been 
appreciated that bacterial cells even within the same species are far from identical, 
and cells within the same population can display multiple distinct behaviors that may 
influence growth and survival.  Despite this impressive diversity, the historical bias 
of thinking of bacteria as identical persists, even when studying bacteria that are 
obviously different from the standard laboratory culture.  This bias has caused 
important questions relating to why and how diversity evolved in the first place to 
be overlooked. 
In this thesis, we attempt to answer the question of why some bacteria within the 
same population adopt very different modes of growth.  In Chapter 2, we use 
mathematical models and experimental approaches to show that by diversifying 
between cell types that are specialized towards either survival or growth, bacteria 
maximize their overall growth over a wide range of conditions.  In Chapter 3, we 
extend the results of Chapter 2 to show the relative degrees that bacteria invest in 
specialized survival and growth cells can evolve in response to antibiotic treatment, 
suggesting that relative investment between cell types may be important in 
considering how to treat infections.  Chapter 4 addresses a specific type of cell that 
can survive antibiotic treatment, called persister cells.  How persister cells are formed 
is not well understood; we hypothesized that the age of the cell might influence 
whether it becomes a persister, but our results indicated this was not the case.  Finally, 
in Chapter 5 we ask whether there are patterns in the traits associated with bacterial 
survival and ‘virulence’, a measure of how much damage the bacteria may cause 
during infection, in a bacteria known for being able to grow in diverse habitats, 
Pseudomonas aeruginosa.  However, we found little evidence for broad patterns 
between traits, reflecting the exceptional diversity that can be achieved even within a 
single species.  
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1   Introduction 
 
 
1.1 The microbial world 
 
Microbes inhabit virtually every niche on the planet, from hydrothermal vents on the 
ocean floor (Lutz and Kennish, 1993) to arctic glaciers (Skidmore et al., 2000) and 
everywhere between.  Microbes are also massively diverse, including the vast 
majority of the three kingdoms of life (bacteria, archaea and eukaryotes); it is simpler 
to say that life is microbial, with the exception of a few peculiar metazoans. Beyond 
their ubiquity and diversity, microbes serve key ecosystem functions on their own as 
producers, decomposers and recyclers.  Furthermore, they are key symbionts to all 
multicellular organisms, including humans, shaping our development and health in 
a number of ways we are only beginning to unravel – as well as pathogens causing 
disease.  Microbes are also highly adaptable, with short generation times leading to 
rapid evolutionary responses to environmental change (Elena and Lenski, 2003), and 
the ability to exchange genetic material horizontally via mobile genetic elements can 
accelerate adaptation to an even greater extent (Jain et al., 2003).   
 
1.1.1 Microbe-human interactions 
Given their ubiquity and adaptability, microbes are a key interacting partner 
influencing human health and disease.  Indeed, a healthy human is roughly equal 
parts human and bacteria (Sender et al., 2016) by crude cell count - and mostly 
bacterial by number of genes.  This vast resident population of microbes living on 
and within us (mostly in the gut) has been collectively named the ‘human 
microbiome’.  Microbiomes provide important site-specific mutualisms, such as 
assisting with the breakdown of food in the gut (which may have wide-ranging 
implications in other aspects of health), training the immune system, and keeping 
skin healthy (Pflughoeft and Versalovic, 2012; Flint et al., 2012).  Dysregulation in the 
microbiome can lead to various negative outcomes (Pflughoeft and Versalovic, 2012), 
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but we are only beginning to appreciate the impact microbiome function has on 
numerous aspects of human health. 
 
1.1.2 Pathogens 
On the other hand, numerous pathogenic microbial species and strains by definition 
induce harm to human hosts in order to reproduce and transmit themselves through 
the environment.  Perhaps the most famous bacterial pathogen is Yersinia pestis, the 
causative agent of the ‘black death’ plague that killed tens of millions of medieval 
Europeans (Dennis and Staples, 2009).  More modern well-known disease agents 
include Vibrio cholerae, responsible for various cholera outbreaks e.g. in the aftermath 
of earthquakes in Haiti (CDC, 2011), or hemorrhagic strains of Eschericia coli, causing 
frequent outbreaks of food-borne illnesses (Sperandio and Hovde, 2015).  Pathogenic 
bacteria can infect and exploit diverse sites by means of numerous virulence 
mechanisms, which generally serve to provide nutrients to the bacteria by killing or 
damaging host cells (e.g. via toxin production in salmonella / VC), and aiding bacteria 
in the evasion of the host immune response (e.g. intracellular replication with 
Mycobacterium leprae, the causative agent of leprosy).  The resident microbiome can 
also interact with pathogens, often functioning to protect against pathogen 
colonization (Buffie and Pamer, 2013; Buffie et al., 2015), but these interactions have 
only just begun to be explored. 
 
1.1.3 Environmental opportunistic pathogens 
In contrast with the largely obligatory pathogens mentioned above, facultative or 
opportunistic pathogenic bacteria are also of concern.  These are species that 
generally exist benignly in the environment or even as commensals with the host, but 
can cause disease when normally present barriers are compromised (hence the 
‘opportunist’ title) - for example with bacterial pneumonia caused by Streptococcus 
pneumoniae, a normal resident of the upper airways in humans.  Opportunists are of 
interest clinically in that infection is not simply tied to exposure to other infected 
individuals, thus making control of transmission problematic (which is of special 
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importance in the consideration of antibiotic resistance, discussed below), while also 
presenting challenges to the theoretical understanding of their evolution (Brown et 
al., 2012) as they do not conform to the standard models of parasite evolution 
(Anderson and May, 1982; Alizon et al., 2009). 
 
1.1.4 Pseudomonas aeruginosa 
Pseudomonas aeruginosa is an environmental generalist microbe, important 
opportunistic pathogen, and the main organism of concern in this work.  It is 
ubiquitous in the environment, having been isolated everywhere from built 
environments, freshwater and marine aquatic sources, soil, plants and animals (see 
Chapter 5 and the Appendix), and in humans it is associated with infections of burn 
wounds, pneumonia, UTIs and surgical site infections, among others, (Driscoll et al., 
2007), and notably as the leading contributor to mortality in patients with cystic 
fibrosis (CF), where it can infect the lungs and persist for years (Davies, 2002; Gaspar 
et al., 2013).  Pathogenicity in P. aeruginosa is governed to a large extent by quorum 
sensing, a regulatory framework by which bacteria can infer information regarding 
both conspecifics (Cornforth and Foster, 2013; Diggle et al., 2007b, 2007a) and physical 
characteristics of the environment (Cornforth et al., 2014).  Quorum sensing broadly 
regulates secreted products, which constitute the bulk of virulence factors such as 
proteases and pyocins produced by P. aeruginosa (Diggle et al., 2007c; Jimenez et al., 
2012), but also influences other clinically relevant phenotypes such as biofilm 
formation and motility (Patriquin et al., 2008; Wang et al., 2014; de Kievit, 2009).  
Furthermore, P. aeruginosa is intrinsically predisposed to resistance to multiple 
antibiotics (Strateva and Yordanov, 2009), the specifics of which will be discussed 
further below. 
P. aeruginosa is notable and potentially unique in the degree of genetic and phenotypic 
diversity it displays in both environmental and infection contexts.  This is likely 
facilitated by its exceptionally rich regulatory networks (Stover et al., 2000; Jimenez et 
al., 2012; Balasubramanian et al., 2013), allowing for precise tuning of physiological 
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states and expanding the capacity for plastic responses to diverse environmental 
conditions and perturbations.   
A paradigm example of this capacity for phenotypic diversity is in the context of CF 
lung infections, where  numerous studies have catalogued extensive heterogeneity in 
phenotypes related to morphology, physiology, virulence, and antibiotic resistance 
(Fonseca et al., 2007; Huse et al., 2010; Starkey et al., 2009; Clark et al., 2015; Workentine 
et al., 2013; Jeukens et al., 2014; Darch et al., 2015).  This diversification is at least in 
part likely driven by differences in numerous extrinsic factors associated with CF 
infections, such as the host immune system, disease progression, other co-localizing 
microbes (of the same and different species), bacteriophage, and chemotherapeutic 
treatments.  While many of these factors are not unique to CF, their effects may be 
magnified given the extreme duration over which populations may persist in the CF 
lung, enhancing the degree of observed diversity within resident populations. 
Furthermore, significant genetic variation within P. aeruginosa has also been noted in 
CF infections, for which the causes and consequences are only recently beginning to 
be unraveled.  From a physical perspective, genotypic diversity in the CF lung is 
facilitated and maintained by spatial segregation of lineages within the lung into 
distinct niches with limited inter-population mixing (Markussen et al., 2014; Jorth et 
al., 2015), suggesting drift may play a significant role alongside adaptive evolution in 
the diversification process (Huse et al., 2010), and facilitating the coexistence of 
distinct lineages through time (Williams et al., 2015).  However, it has also been noted 
that within-sample (i.e. within a single sputum exudate) variation is often greater 
than variation between samples or between patients (Winstanley et al., 2016; Mowat 
et al., 2011; Ashish et al., 2013), indicating that within-local population processes 
remain the dominant driver of diversification.  This is not surprising, given that 
numerous aspects of the CF lung environment can facilitate within-population 
genetic and phenotypic diversification, such as the nutritional environment (Wong et 
al., 2012), growth primarily within biofilms (Boles et al., 2004; Boles and Singh, 2008; 
Wessel et al., 2014; Starkey et al., 2009), exposure to antibiotics (Wright et al., 2013), 
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social dynamics (Andersen et al., 2015; van Gestel et al., 2015), and persistence of 
mutator strains (Ciofu et al., 2010). 
There has been limited success in mapping genotypic markers of P. aeruginosa to 
phenotypic outcomes in the CF lung (Fonseca et al., 2007; Jeukens et al., 2014; Hilker 
et al., 2015; Clark et al., 2015; Darch et al., 2015).  The reasons for this lack of 
predictability remain unclear, but candidate processes include plastic phenotypic 
responses in the absence of genetic change, and mutations occurring in global 
regulators where specific phenotypic outcomes may be difficult to elucidate 
(Damkiær et al., 2013).  Mapping phenotypic outcomes onto genetic determinants 
remains an open question in infections of P. aeruginosa within the CF lung, and more 
generally is broadly important to disease ecology, as similar diversifying processes 
have been observed in P. aeruginosa infections in other disease sites (Buivydas et al., 
2013), hosts (Wright et al., 2015), as well as in populations of other microbial 
pathogens (Goerke et al., 2007; Lieberman et al., 2014). 
 
1.2 Pathogen control and drug failure 
Control of pathogenic bacterial infections is mediated jointly by pharmaceutical 
treatment of infections, and by limiting pathogen transmission via epidemiological 
control and vaccination.  Control of transmission is particularly effective against 
obligate pathogens, which generally have limited access to external reservoirs and 
therefore rely on rapid between-host transmission to spread throughout the 
population (Anderson and May, 1990).  For example, limiting contact with rodent 
species (and their associated flea vectors) has largely mitigated outbreaks of the 
bubonic plague (Dennis and Staples, 2009).  Opportunists, on the other hand, require 
more holistic approaches given the high rates of contact, and rely more heavily on 
antibiotic treatment (especially when vaccination is unavailable)  for control (Brown 
et al., 2012).  However, the capacity for rapid adaptation in bacteria has led to the 
evolution of numerous mechanisms to resist antibiotic killing and vaccine control, 
and through heavy usage we have arrived at a crisis point in antimicrobial resistance 
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(Rossolini et al., 2014), with strains emerging that are resistant to most or in some 
cases all of our current antibiotic arsenal. 
 
1.2.1 Antimicrobial resistance 
Antimicrobial resistance (AMR) is defined as an increase in the concentration of drug 
required to prevent any bacterial growth (the minimum inhibitory concentration, or 
MIC) (Brauner et al., 2016), and can be mediated through one or a combination of 
several molecular mechanisms, including direct degradation of antibiotic molecules, 
modification of the cellular targets of antibiotics, blocking uptake of antibiotics into 
the cell, or using efflux pumps to reduce the intracellular antibiotic concentration 
(Blair et al., 2014).  Increases in AMR can result from regulatory shifts that increase 
expression of existing defensive mechanisms, and/or genetic changes leading to 
increased AMR functionality.  Furthermore, genes mediating the above resistance 
mechanisms can be packaged into mobile genetic elements, which can facilitate rapid 
spread of resistance genes throughout microbial populations via horizontal gene 
transfer.  This is particularly troublesome when multiple resistance alleles are 
packaged onto a single transmissible element, as uptake then confers multiple 
antibiotic resistances to an otherwise susceptible organism in a single step (Kruse and 
Srum, 1994). 
 
1.2.2 Antimicrobial tolerance 
Further compounding the problem of AMR are various phenotypic states which 
reduce the killing efficacy of antibiotics in otherwise genetically susceptible cells 
(Figure 1.1).  With antibiotic tolerance, otherwise genetically susceptible cells can 
transiently survive antibiotic treatment due a decrease in the rate of killing relative to 
susceptible cells (though susceptibility remains over longer time scales) (Brauner et 
al., 2016).  In the simplest case, tolerance can result from the correlation between 
antibiotic killing rates and the growth rate of the population (Tuomanen et al., 1986); 
therefore, various situations that reduce bacterial growth rates may increase 
antibiotic tolerance.  Even transitory suppression of growth can increase antibiotic 
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tolerance, for example by extending the duration of the lag phase before growth 
begins, potentially altogether evading transient antibiotic exposure (Fridman et al., 
2014).  In the following paragraphs, I discuss two specialized cases where 





Figure 1.1:  Resistance, tolerance and persistence reduce antibiotic efficacy.  
Schematic curves show viability through time for bacterial populations exposed to 
antibiotics, illustrating the signatures of various phenotypic classes that reduce 
antibiotic efficacy compared to susceptible cells.   Resistance results in no killing, and 
can be mediated both genetically and phenotypically.  Tolerance results in a decline 
in the rate of killing relative to susceptible cells, while persistence is indicated by a 




Persister cells are a distinct subpopulation identified by a biphasic death curve upon 
exposure to antibiotics (Figure 1.1), where the vast majority of the population dies off 
rapidly while a small subpopulation (at an average frequency of approximately 10-5) 
‘persists’ for an extended period of time (Keren et al., 2004b, 2004a; Brauner et al., 
2016).  Persister cells are generally thought to arise through transient metabolic arrest 
due to stochastic induction of toxin-antitoxin (TA) modules (Lewis, 2010; Wood et al., 
16 
 
2013).  Briefly, TA systems consist of a durable intracellular toxin and a labile 
antitoxin, which must be constantly produced in order to neutralize toxin activity, 
and their evolutionary origin is a subject of debate (Van Melderen and De Bast, 2009).  
It is hypothesized that stochastic dysregulations in cellular metabolism and/or 
signaling can transiently induce metabolic arrest by activating TA modules (Gerdes 
et al., 2005; Maisonneuve et al., 2013b; Lewis, 2010; Wood et al., 2013; Nguyen et al., 
2011); however, apparent genetic redundancy in the persister phenotype (Hansen et 
al., 2008) combined with the general difficulty in studying rare heterogeneous 
phenotypes have made elucidation of the details of persister formation elusive. 
 
1.2.4 Biofilms and phenotypic resistance 
Finally, biofilms, a major theme of this thesis, represent a key phenotypic class 
conferring tolerance and resistance to antibiotics.  Biofilms are conventionally defined 
as dense clusters of surface attached cells encased in a polymer matrix (extracellular 
polymeric substance, EPS) composed of a combination of polysaccharides, protein 
and extracellular DNA (Hall-Stoodley et al., 2004); the matrix may also harbor active 
factors such as degradative enzymes or signaling molecules (Flemming and 
Wingender, 2010).  In this thesis, we adopt a broader definition of biofilms as any 
multicellular group of attached bacteria – including pellicles (mats of cells at the air 
liquid interface), suspended aggregates of cells (Schleheck et al., 2009; Haaber et al., 
2012), and microcolonies (smaller clusters of surface-attached cells) (Monds and 
O’Toole, 2009).  Biofilms are generally accepted to be a ubiquitous feature of bacterial 
growth, and thought to develop via a loose biphasic life cycle where the adhered 
biofilm functions as the ‘soma’ and motile planktonic cells as the dispersive 
propagules (Monds and O’Toole, 2009; O’Toole et al., 2000). 
Biofilm cells grow slowly relative to their planktonic counterparts, likely due to 
limitations on nutrient diffusion and spatial constraints (Stewart, 2003).  Slowed 
growth, limited resources and the physical barrier provided by the matrix combine 
to provide biofilm cells with exceptional ‘phenotypic resistance’ not only to 
antibiotics, but to a wide array of external threats, including chemical insult, 
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desiccation, predation, bacteriophages, and host immune cells and factors (Strateva 
and Yordanov, 2009; Wiuff et al., 2005; Vega and Gore, 2014; Corona and Martinez, 
2013; Van Acker et al., 2014; Matz et al., 2008).  EPS also functions as a physical glue, 
adhering the biofilm cells to the surface and making physical removal of biofilm cells 
difficult as well.  This general recalcitrance leads to biofilms causing problems not 
only when attempting to be treated in an infection site within a host, but also when 
transmitted on e.g. medical devices (Francolini and Donelli, 2010; Marks et al., 2014; 
Kramer et al., 2006), as well as in numerous industrial applications in which surface 
fouling is undesirable (e.g. shipping and food safety). 
This general recalcitrance has led to much work devoted to understanding the cues 
and signals regulating biofilm formation and dispersal, often with the aim of 
developing novel methodologies to prevent colonization or facilitate their removal.  
In P. aeruginosa, biofilm formation is a multifactorial process, with colonization being 
sensitive to QS signals (de Kievit, 2009; Karatan and Watnick, 2009) and physical 
factors such as flagella and pili (Wang et al., 2014; Belas, 2014; O’Toole and Kolter, 
1998), while dispersal can be induced by environmental cues such as starvation, 
nutrient induction, changes in iron or oxygen availability, or the presence of 
competitors (Huynh et al., 2012; Taylor and Buckling, 2010; Sauer et al., 2004; 
McDougald et al., 2011).  Considerable study has also been devoted to understanding 
the process of endogenous dispersal (as part of the developmental program discussed 
above), which relies on c-di-GMP, a global regulator of the biofilm phenotype (Ueda 
and Wood, 2009; Valle et al., 2013; Lori et al., 2015; Starkey et al., 2009): endogenously 
produced NO as well as quorum sensing signals interact to alter levels of c-di-GMP 
(Barraud et al., 2006; Ueda and Wood, 2009), which goes on to regulate expression of 
surfactants, phages and other degradative factors which facilitate dispersal from the 
biofilm (Harmsen et al., 2010; Kaplan, 2010; McDougald et al., 2011).   
While there is intense interest in plastic regulatory responses governing biofilm 
formation, many evolutionary aspects of biofilm formation remain poorly 
understood, though this appears to be changing with several important recent 
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studies.  For example, dispersal phenotypes from the biofilm have been linked to 
social evolution dynamics, with ‘cheater’ lineages that exploit biofilm investment (by 
not producing EPS matrix – though we note there is some contention as to whether 
matrix production is indeed a cheatable phenotype, and this may depend on the 
species and even specific component under investigation (Xavier and Foster, 2007; 
Irie et al., 2016)) being proposed as primary dispersal agents in a primitive form of 
division of labor (Hochberg et al., 2008; Hammerschmidt et al., 2014), and in line with 
the biphasic life cycle model previously proposed.  The relative degree and mode of 
dispersal may also be an important factor for biofilm transmission.  For instance, 
dispersal via multicellular aggregates may confer fitness benefits upon subsequent 
colonization (Kragh et al., 2016; Melaugh et al., 2016); dispersal via this mechanism 
may also help to alleviate Allee effects associated with subsequent colonization 
(Smith et al., 2014) or maintain cooperativity within the group (Kümmerli et al., 
2009a).  Growth within and dispersal from biofilms also facilitates diversification in 
cellular morphotypes and physiology (Stewart and Franklin, 2008; Rainey and 
Travisano, 1998; Kassen et al., 2004), and this diversification can be leveraged to 
optimize dispersal and colonization cycles imposed via experimental evolution 
(Poltak and Cooper, 2010; Hammerschmidt et al., 2014).  Given the capacity for 
biofilms to potentiate AMR, further exploration of the evolutionary causes and 
consequences of biofilm formation likely hold important insights towards their 
effective management in the clinic. 
 
1.3 Synopsis 
The work presented here is aimed to sit at the intersection between antimicrobial 
resistance, phenotypic heterogeneity, and evolutionary ecology.  As reviewed above, 
heterogeneous phenotypes (e.g. biofilms, persisters, etc.) contribute to failure of 
antibiotic treatment, and may lead to evolution of genetic resistance; furthermore, the 
ecological and evolutionary causes and consequences of these diverse phenotypes 
remain largely unexplored (Figure 1.2).  We hypothesize that better understanding of 
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the evolutionary dynamics of phenotypic heterogeneity conferring tolerance or 
resistance to antibiotics will yield insights into defining effective treatment strategies 
in the face of the antibiotic resistance crisis.  Four projects seeking to move towards 
this goal are summarized below. 
 
 
Figure 1.2:  Intersection of AMR, evolution and heterogeneous phenotypes.  The 
influence of heterogeneous phenotypes and evolution on antibiotic resistance are 
well established, but the interactions between evolution and heterogeneous 
phenotypes on AMR evolution remain poorly understood. 
 
In Chapter 2, we use a combination of theoretical and experimental approaches to 
construct and validate a population dynamical model of a bacterial lineage that may 
allocate cellular resources between two specialized phenotypes: robust biofilm cells, 
and fecund planktonic cells.  Our model predicts that conditions restrictive to growth 
favor trade-offs between the two fractions, with resource allocation devoted to 
whichever phenotype is favored for transmission.  Under more permissive 
conditions, however, we find that populations can leverage reproduction in the 
planktonic phase to drive expansion in the biofilm, resulting in mixed investment 
strategies even when planktonic cells provide no transmission routes to future 
growth patches.  Using experimental evolution, we show that phenotypic 
heterogeneity is tunable, but always maintained in P. aeruginosa when transmission 
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is restricted to solely planktonic or solely biofilm cells.  Furthermore, our model 
predicts a hump shape between biofilm and planktonic cell densities due the 
planktonic ‘growth engine’, which was consistent with the relationship observed 
across a library of over 200 natural isolates of P. aeruginosa.  We also found indications 
that biofilm may function as a cost-effective hedge against environmental 
catastrophe.  This work indicates that the reverse conceptualization of the biofilm life 
cycle – i.e., where the ‘soma’ is composed not of the biofilm but of rapidly dividing 
planktonic cells, and biofilm aggregates function as dispersal propagules – is not only 
viable, but favored under a broad range of environmental conditions. 
Chapter 3 expands the reasoning in Chapter 2 to the clinical problem of antibiotic 
resistance.  Specifically, we ask whether biofilm-mediated phenotypic resistance is an 
evolvable trait, and whether phenotypic resistance helps or hinders evolution of 
conventional genetic resistance mechanisms.  To answer these questions, we 
experimentally evolved populations of the opportunistic pathogen P. aeruginosa 
exposed to antibiotics, with treatments manipulating the type and dose of antibiotic, 
as well as which cellular fraction (biofilm or plankton) was passaged, and monitored 
the relative cell densities in the biofilm and planktonic fractions through time.  
Preliminary experimental results suggest that phenotypic resistance is evolutionarily 
labile (i.e. not simply a plastic response to environmental conditions), and responsive 
to the complex costs associated with the interaction between antibiotic and 
transmission environments.  However, further study, particularly acquisition of 
genetic information, will be necessary to confirm these observations.  Nevertheless, 
the preliminary results suggest that phenotypic resistance is an important component 
contributing to antibiotic treatment failure, and can evolve in a similar manner as 
conventional resistance mechanisms. 
In Chapter 4, focus is shifted towards persistence.  We hypothesize that persister 
formation at the individual cell level is not fully stochastic, but instead driven by 
demographic determinants; specifically, we hypothesized that cellular age drives 
persister formation, as phenotypes associated with cellular aging in bacteria agree 
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well with those attributed to persistence.  We tested this hypothesis by segregating 
cells based on age using fluorescence-activated cell sorting (FACS) and a strain of E. 
coli with a fluorescent label whose brightness correlates with the age of the cell.  
However, no differences in persister fraction were detected between the age-
fractionated subpopulations.  Still, we posit that seeking other non-genetic 
determinants (for instance biochemical parameters such as metabolic activity or 
membrane potential) will be important in determining both the proximate and 
ultimate causes of persister formation, and will become more accessible as single-cell 
assay technologies improve. 
Finally, in Chapter 5 we seek to investigate the extent and patterns of natural 
variation across a range of bacterial phenotypes liked to virulence and resistance by 
screening a diverse library of 230 natural and clinical isolates of P. aeruginosa.  While 
probing isolate libraries regarding a phenotype of interest is relative common, 
understanding how virulence and resistance determinants co-vary outside of the 
laboratory is relatively unknown, and the ubiquity of P. aeruginosa in both natural 
and clinical settings provides an unparalleled source of natural diversity to probe.  
We find that phenotypes are highly variable across isolates, but the environmental 
source of the isolates does leave a significant trace on several phenotypes including 
antibiotic resistance, biofilm composition and siderophore preference.  Gross patterns 
suggest phenotypes may segregate into ‘survival’ (high biofilm, low 
growth/virulence) and ‘virulent’ (high growth/virulence, low biofilm), but this only 
explained a small portion of overall variance in phenotypes.  However, using 
environmental source as a proxy for evolutionary history is problematic, and work is 
currently underway to sequence the genomes of all 230 isolates, and build a robust 
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2.1 Abstract 
Bacterial cells, just like multicellular organisms, face tradeoffs between longevity and 
fecundity. ‘Planktonic’ cells are fast growing and fragile, while ‘biofilm’ cells (also 
spores or persisters) are slower growing and more resistant. Here we ask, why do 
bacterial lineages invest simultaneously in both fast and slow growing types? We 
develop a population dynamical model of lineage expansion across a patchy 
environment, and find that mixed investment is favored across a range of 
environmental conditions, even when transmission is entirely via biofilm cells - this 
is because of a division of labor, where exponentially dividing planktonic cells can 
act as an engine for the production of future biofilm cells, which grow more slowly.  
We use experimental evolution to test our predictions, and show that phenotypic 
heterogeneity is persistent even under selection for purely planktonic or purely 
biofilm transmission. Our model further predicts a humped relationship between 
biofilm and planktonic cell densities due to the ‘growth engine’ effect of planktonic 
expansion, and we find support for this relationship using a comparative analysis of 
over 200 isolates of the opportunistic bacterial pathogen P. aeruginosa. 
2.2 Introduction 
After billions of years of evolution, few opportunities remain for organisms to gain 
increases in survival or reproduction that are not subject to trade-offs in other traits.  
Indeed, understanding how adaptation occurs when key fitness parameters trade off 
lies at the core of life history theory (Stearns, 1992). While most life history theory has 
been developed with large multicellular organisms in mind, microbes also exhibit 
classical trade-offs in fecundity and longevity, with faster growing lineages tending 
to be more fragile (De Paepe and Taddei, 2006; Heineman and Brown, 2012). 
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Understanding how microbes manage such trade-offs remains a major goal in 
microbiology, both from mechanistic (Gudelj et al., 2010) and ecological (Green et al., 
2008) perspectives.  
Multiple mechanisms of enhancing durability and longevity are available to 
microbes, but typically come at the cost of reduced metabolic proficiency.  Spore 
formation is perhaps the clearest example of a high survival, low fecundity 
phenotype; by encasing the genome and some essential metabolic machinery in a 
thick and extremely resistant cell wall, dormant spores can survive for extraordinarily 
long durations (Cano and Borucki, 1995; Vreeland et al., 2000). Alternatively, cells 
may form metabolically dormant persister cells capable of surviving diverse 
environmental insults (Lewis, 2010; Wood et al., 2013). Finally, many microbial 
species form biofilms where dense cell packing leads to limits on space and nutrient 
availability, thereby reducing growth rates and gaining broad resistance to stressors 
such as desiccation, predation, or chemical insult (Van Acker et al., 2014).   
Clonally reproducing microbes present an interesting and experimentally tractable 
system to examine mixed-behavioral strategies.  Across many species of microbe, 
single genotypes can produce coexisting subpopulations of rapidly dividing 
planktonic cells and slow-growing or dormant stress-tolerant cells, but focus is often 
given to a specific phenotype of interest rather than the balance between alternate 
phenotypes.  In this study, we examine how the trade-off between survival and 
growth of individual cells drives the evolution of mixed biofilm / planktonic 
investments on a lineage scale under diverse environmental conditions.  Specifically, 
we build population dynamical models of bacteria in patchy environments, where 
cells can switch between biofilm and planktonic states within ephemeral patches (via 
biofilm colonization and dispersal), and can also transmit among patches either as 
biofilm or planktonic cells. We then ask, under what conditions is investment into 
biofilm favored, given that biofilms grow more slowly?  If only one phenotype (i.e. 
biofilm or plankton) is favored for transmission to a new patch, does it ever pay to 
diversify into the cell type that is, from a transmission perspective, a ‘dead end’? Our 
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model predicts that phenotypic diversification can pay across a range of 
environmental conditions, as rapidly growing planktonic cells can function as a 
‘growth engine’ providing higher levels of future planktonic and biofilm cells for 
transmission. We then test our model predictions using stochastic simulations, 
experimental evolution and comparative analyses of biofilm allocation in the 
environmental microbe Pseudomonas aeruginosa. 
2.3 Methods 
2.3.1 Biofilm allocation experiment  
A diverse library of 235 natural and clinical isolates of P. aeruginosa was kindly 
provided by Dr. G Perron (Bard College), see the Appendix for strain information.  
Each strain was grown to mid-exponential phase in 1 mL ‘growth medium’ (M9 salts 
supplemented with 10 mM Glucose, 1% Cas-amino acids, 1mM MgSO4, 100uM CaCl2 
and 1X Hutner’s trace elements (Hutner et al., 1950)) in a 48-well plate, and these 
starter cultures were used to inoculate 150 uL of fresh growth medium in a tissue 
culture-treated 96-well plate at an OD(600) of 0.05.  Plates were incubated statically 
in a humidified chamber at 37 °C for 6 hours; this time was chosen to minimize plastic 
phenotypic changes that commonly occur as P. aeruginosa enter stationary phase.  
After growth, the OD(600) of the planktonic phase was measured, then removed and 
the attached biofilms washed with sterile water via pipetting.  150 mL of sterile 0.85% 
NaCl was then added to each well, along with 5-10 sterile 1 mm glass beads.  The 
plate was then sealed with acetate tape and vortexed at 2000 rpm for 15 minutes to 
resuspend the attached biofilm; the resuspended biofilm was then transferred to a 
new 96-well plate and the OD(600) measured. 
2.3.2 Passaging experiment  
A mid-exponential phase culture of P. aeruginosa PA01 was used to inoculate 200 uL 
LB and one 4 mm sterile glass bead in each of 24 wells in a 96 well plate at an OD of 
0.05.  Plates were sealed with Aeraseal tape and grown statically at 24 °C in a 
humidified chamber.  Every 12 hours (again, growth conditions were chosen to 
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prevent entry into stationary phase), biofilm allocation was measured by removing 
and measuring the OD(600) of the planktonic phase, then washing, resuspending and 
measuring the density of the attached biofilm as above in 200 uL fresh LB.  12 lines 
had only the planktonic cells passaged, while the other 12 had only biofilm cells 
passaged; in each case, cells were diluted to an inoculum OD of 0.05, and 20 passages 
were performed. 
2.3.3 Statistics and mathematical analysis 
All non-analytical modelling and statistics were performed in R (Soetaert et al., 2010; 
R Core Team, 2015), unless otherwise noted.  Agent based simulations were 
performed using iDynoMiCs (Lardon et al., 2011), and analytical analyses were 
performed using Mathematica (Wolfram, 2015). 
2.4 Results 
2.4.1 Biofilm Growth Dynamics 
While it is well known that planktonic cells accumulate exponentially in nutrient-rich 
environments, it is less clear whether close-packed biofilm cells would suffer any 
penalty to growth under similar conditions (note that here we are considering biofilm 
growth in the absence of any coupling with the planktonic compartment, i.e. no cells 
dispersing from the biofilm or colonizing from the bulk).  We hypothesize that when 
the surface on which the biofilm grows is sparsely colonized, lineages can grow 
exponentially.  However, once confluence across the surface is reached, further 
growth is restricted to linear expansion in the z-direction (i.e. towards the bulk), due 
to cell division being largely restricted to a fixed depth within the outermost layer in 
biofilms due to space and diffusion limitations (Werner et al., 2004; Fux et al., 2005).  
We explore this conjecture using the individual-based simulation platform 





Figure 2.1: Biofilms grow linearly.  Agent-based simulations of a 2D biofilm growing 
on a surface.  A, accumulated cells and B, lineage growth rate through time. Varying 
inocula (see legend) were allowed to grow for a fixed time period under nutrient-rich 
conditions.  Smaller inocula (i.e. sparse colonization) lead to prolonged periods of 
exponential growth that decay to linear growth once confluent colonization occurs 
(under these conditions, after roughly 100 cells have accumulated, at a rate of 50 
cells/time step).  Simulations were implemented using the agent-based simulation 
platform iDynoMiCS (Lardon et al., 2011). 
 
The simulations support our conjecture that biofilm lineage growth plateaus at some 
maximal rate constant, likely influenced by the nutrient diffusion rates and cell 
packing efficiency specific to each instance considered.  Small inocula (i.e. low surface 
coverage; Figure 2.1, solid line) showed an extended period of exponential growth 
that eventually decayed to linear accumulation, and as the inoculum size increases, 
the duration of exponential growth decreases until it disappears completely for large 
initial populations (Figure 2.1, dot-dash lines). Figure 2.1 highlights that while biofilm 
cells do not face the extreme growth penalty of resistant spores or persister cells, they 
face a significant and compounding growth deficit in comparison with the 
exponential growth of planktonic populations.  
2.4.2 Coupled Biofilm-Plankton Dynamics 
We next model a growing bacterial microcosm within which cells grow in one of two 
compartments, the planktonic (P) phase within the bulk fluid, and the biofilm (B) 
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phase attached to a surface and in contact with the bulk.  The compartments are 
coupled, such that biofilm cells can disperse to the planktonic phase, and planktonic 
cells can colonize the biofilm.  Cells in each compartment also divide, with planktonic 
cells growing exponentially, and biofilm cells growing linearly (Figure 2.1). 
Because the biofilm is limited to linear expansion, we reasoned that the effects of 
growth within and dispersal from the biofilm would be negligible when coupled to 
exponential growth in the planktonic phase.  This simplification was shown to be 
reasonable by comparing numerical simulations of the full and simplified models 
(Supplemental Figure 2.1), yielding the model system outlined in Figure 2.2A, and 
Equations 1.1, 1.2, 2.1 and 2.2 for within-patch growth. 
We also note that setting the growth of the biofilm to zero in the simplified model 
framework renders biofilm cells functionally equivalent to spores or persister cells as 
described above, i.e. a subpopulation of non-dividing cells supported by the growth 
of vegetative cells, which presumably must provide some other benefit (e.g. 
environmental resistance) to the overall population to counteract this loss in fitness, 
or else be lost from the population. 
Our simplified model framework results in the following coupled differential 
equations: 
1.1)    
𝑑𝑃
𝑑𝑡
= (𝑟 − 𝑐)𝑃 
1.2)    
𝑑𝐵
𝑑𝑡
= 𝑐𝑃  
Solving equations 1.1 and 1.2 as a function of time yields our within-patch population 
model, 
2.1)    𝑃(𝑡) =  𝑃0𝑒(𝑟−𝑐)𝑡 
2.2)    𝐵(𝑡) =  
𝑐
𝑟 − 𝑐
(𝑃(𝑡) − 𝑃0) 
where r is the exponential growth rate, c is the rate of colonization of the biofilm (with 
0 ≤ c  r), and P0 is the planktonic inoculum.  Note that in general c need not be 
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bounded by r, and arbitrarily high values for c would result in a decline in P as 
switching to the biofilm phase outpaces planktonic growth, giving a trade-off 
between the two fractions; we discuss this case in the context in which it arises below. 
 
 
Figure 2.2:  Trade-offs in duration and rate of growth lead to maximal biofilm at 
intermediate rates of colonization.  A, Schematic model process.  B and C, time series 
of planktonic and biofilm cells, respectively, for low to high colonization rates c 
(yellow-purple color scale).  c is normalized to 40 – 99% of r, with r = 0.08.  Note that 
decreasing c allows for greater rates of exponential expansion in the biofilm (yellow 
curve represents approximately linear growth in the biofilm).  D, planktonic, and E, 
biofilm cells as a function of colonization rate relative to growth rate for t = 40, 0.02 ≤ 
r ≤ 0.12 (blue-red color scale), P0 = 5,000,000.  F, Relative colonization rate at which 
biofilm is maximized.  Note in panel E the limit of c = 0 is omitted, as this prevents 
any formation of biofilm cells. 
 
As expected, planktonic cells decline monotonically with increasing colonization rate 
c, as more cells are siphoned from the planktonic to the biofilm compartment (Figure 
2.2, B and D).  The biofilm, however, shows more interesting dynamics with changing 
rates of colonization (Figure 2.2, C and E).  At c = 0, no biofilm cells accumulate, while 
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at c = r, all new planktonic cells colonize the biofilm, resulting in a static planktonic 
population and linear accumulation of biofilm cells (P0 cells per time step; Figure 2.2, 
yellow lines).  However, when the planktonic fraction is allowed to expand 




 of the planktonic population, leading to a temporal trade-off in 
total biofilm with increasing c (Figure 2.2C), where high colonization rates provide 
more biofilm cells at short time scales, while lower colonization rates maximize 
biofilm over longer periods of growth.  
The conditions governing a maximum in biofilm at c < r are explored in Figure 2.2E 
and F and in Equation 2.3.  In Figure 2.2E, biofilm initially increases with c, but at 
higher growth rates we see a hump shape appear, with further allocation to the 
biofilm reducing the number of biofilm cells, similar to the temporal trade-off in 
Figure 2.2C.  We can solve for an analytical condition for this humped relationship 
by examining the slope of B as a function of c as c approaches r (Equation 2.3, see 
supplemental data for derivation).  








𝑃0𝑡(𝑟𝑡 − 2) 
If the slope is negative, this would imply an interior maximum in B at some c < r (as 
biofilm cells necessarily increase as c increases from zero).  We find that this limit is 
negative for rt > 2, i.e. the presence of a humped relationship in B requires patch 
quality to exceed some minimal threshold value, and thereby explaining the parallel 
trade-offs in biofilm accumulation with changing r and t (Figure 2.2F). 
2.4.3 Evolutionary Model 
Given that any allocation of resources to the biofilm comes as a direct cost to total cell 
number, what conditions would favor maintenance of a biofilm?  We can examine 
the evolutionary consequences of allocation in the within-patch population model by 
constructing a life cycle in which a population colonizes successive patches through 
space and/or time.  We define a fitness function (Equations 3.1 and 3.2) by assigning 
transmission probabilities kp and kb that a given cell from the respective planktonic or 
30 
 
biofilm compartments will go on to found a new patch (analogous to the reproductive 
number ‘R0’ framework common to parasite virulence, e.g. Frank 1996).   
3.1)    𝑊 = 𝑘𝑝𝑃(𝑡) + 𝑘𝑏𝐵(𝑡),  
or, explicitly, per-founding cell  






Equation 3.2 allows us to interrogate the fitness consequences of colonization rate 
across a wide array of ecological parameters.  kp and kb capture the reproductive value 
of each cell type, and can be interpreted equivalently as a per-cell transmission 
probability or as the fraction of the population able to transmit successfully; they 
dictate how well a given cell can survive the inter-patch transition, and are influenced 
by the nature of the environment.  Growth time t describes the disturbance regime, 
i.e. how long a population can stay in a single patch, and r measures the nutrient 
quality of individual patches, or how rapidly planktonic cells can divide within the 
patch.  We define c* as the optimal colonization rate (the rate maximizing fitness W 
under a given ecological condition), and display the behavior of c* as a function of 





Figure 2.3:  Optimal colonization rate c* as a function of reproductive value for 
planktonic and biofilm cells.  Contour plots showing the relative colonization rate 
(c*/r, yellow-purple color scale) optimizing fitness (Equation 3.2).  Each panel 
displays c*/r as a function of kp and kb.  Across panels, the growth rate r increases from 
r = 0.02 to 0.12, with t = 40 in all cases; similar plots varying t are displayed in 
Supplemental Figure 2.2.  White dotted line indicates the threshold at which c* > 0, 
and black dotted line indicates the threshold at which c* < 1. 
 
There are three general strategies populations may adopt in maximizing fitness: 
devoting all resources to the biofilm fraction (c* = r), splitting resources between the 
two fractions (0 < c* < r), or devoting all resources to the plankton (c* = 0).  We 
investigate the conditions governing the two transitions defining these regimes by 
examining the behavior of Equation 3.2 in more detail. 
 
2.4.3.1 Biofilm only / coexistence threshold 
To examine the case where biofilm is maximally favored, we follow a similar logic to 
that employed in the analysis of the within-patch model in Equation 2.3 by examining 
the slope of W as c approaches r (see supplemental data for derivation): 
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𝑡(2𝑘𝑝 + 𝑘𝑏(𝑟𝑡 − 2)) 
In the limiting case of kp = 0, we recover an equivalent scenario to that in equation 2.3, 
where biofilm (and thereby fitness) increases as c moves away from the minimum at 
zero, and is maximized at c* = r for rt < 2 (i.e. 
𝑑𝑊
𝑑𝑐
 is always positive and approaches 






, and at 






, setting the condition separating the strict trade-off and 
coexistence fitness regimes (black dashed lines, Figure 2.3). 
 
2.4.3.2 Coexistence / plankton only threshold 
Sole investment into the planktonic phase will be favored when fitness is maximized 
at c* = 0; for our model, this condition is met when 1) 𝑊(𝑐 = 0) > lim
𝑐→𝑟
(𝑊), i.e. fitness 





< 0, i.e. the decline in fitness is monotonic.  
Evaluating Equation 3.2 under condition 1 yields 
3.4)   𝑘𝑝𝑒
𝑟𝑡 >  𝑘𝑝 + 𝑘𝑏𝑟𝑡, 
while condition 2 gives 
   
𝑘𝑏
𝑟
(𝑒𝑟𝑡 − 1) −  𝑘𝑝𝑡𝑒
𝑟𝑡 < 0, 
which simplifies to 




(𝑒𝑟𝑡 − 1). 
Both conditions are linear in kp and kb; solving for kp as a function of kb in equations 
3.4 and 3.5 and comparing the slopes reveals that Equation 3.5 presents the higher 
threshold for all values of r and t examined in this work (data not shown).  Therefore, 
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2.4.3.3 Trade-offs in allocation 
Strict trade-offs are defined by the regions where c* = r and c* = 0.  This region covers 
nearly all of the transmission space at low growth rates (Figure 2.3), where divergent 
selection towards one extreme or another is expected, and relaxes as conditions 
become more permissive to growth.  In the limit of zero within-patch growth, the 
allocation decision becomes a ‘zero-sum’ game: 





= 𝑡𝑒−𝑐𝑡(𝑘𝑏 − 𝑘𝑝) 
If kb > kp, c will increase to the limit of c* = r, while kp > kb will cause c* to decline to 
zero, giving a strict trade-off defined by whichever fraction is preferentially 
transmitted between patches. 
This simple zero-sum logic is intuitive, but fails significantly under more permissive 
growth conditions (i.e. increasing r and/or t; Figure 2.3 and Figure S2.2), where we 
see an intermediate level of colonization is favored over a relatively large portion of 
the parameter space.  Despite large transmission advantages to biofilm cells, the 
intermediate colonization regime extends to the boundary of kp = 0 (black dashed line 
undefined for r > 0.04, Figure 2.3), such that even when planktonic cells have zero 
probability of founding a new patch, the vast majority of the population is still 
allocated to that fraction. 
Why would such a small fraction of replicating cells be allocated to the biofilm when 
that is the only source of reproductive value to the population?  To address this, we 





Figure 2.4:  Biofilm is maximized at reduced colonization rates with increasing 
growth rates.  A, Solutions to the within-patch model (Equations 2.1, 2.2) are plotted 
for t = 40, 0.02 ≤ r ≤ 0.12 (blue-red color scale), P0 = 5,000,000 (same as in Figure 2DEF).  
Biofilm cells are plotted against planktonic cells to show regions of positive slope, 
with colonization rate decreasing from r at the left end of each curve and approaching 
zero at the right end (the point where c = 0 is omitted), and the maximum in biofilm 
marked along each curve.  B, Solutions to the within-patch model are plotted as in A, 
but with r and c combinations biased to reflect expectations for analogous 
experiments in panel C (see main text).  Inset depicts putative relationships between 
r and c, and are matched to the main panel via line type.  C, Population allocation for 
a library of P. aeruginosa natural isolates, with each point representing a single strain.  
Dashed curve in C depicts the regression of biofilm OD onto a quadratic in planktonic 
OD (see main text). 
 
As was noted in Figure 2.2C and 2.2F, reducing the colonization rate away from the 
maximum allows for exponential growth in both fractions of the population, yielding 
more biofilm cells at lower rates of colonization given sufficiently long periods or fast 
rates of growth.  This results in a transition from a trade-off to a hump shape in the 
allocation space as the opportunity for within-patch growth is increased (Figure 
2.4A).  At low r (blue lines), the expected outcome of a trade-off between biofilm and 
planktonic cells across c is recovered as discussed above: increasing the number of 
cells in either compartment comes at a direct cost to the other.  As r increases (red 
lines), two separate regimes emerge.  Moving from left to right along the trajectories, 
a positive relationship is maintained between biofilm and planktonic cells as c 
decreases, up to some intermediate value of c maximizing biofilm (diamonds in 
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Figure 2.4A; also see Figure 2.2F).  As colonization decreases beyond this point, 
biofilm declines sharply as colonization tends to zero.   
The colonization rates maximizing biofilm (points in Figure 2.4A) represent the 
points at which the effective colonization rate (i.e. in cells per unit time, not as a 
proportion of the planktonic population, as in all cases up to this point) is maximized 
for a given set of growth conditions.  In other words, the planktonic fraction may be 
viewed as a ‘growth engine’ for the biofilm: when within-patch conditions are 
sufficiently favorable to planktonic division (Equation 2.3), reducing the colonization 
rate c increases the net flux of cells into the biofilm by expanding the pool of dividing 
planktonic cells, P.  This growth engine effect is sufficient to drive colonization rates 
down to a fraction of the growth rate, even when planktonic cells provide no 
reproductive benefit to the population (Figure 2.3, Figure 2.2F). 
We sought to validate our model findings in Figure 2.4A by measuring population 
allocation between the biofilm and planktonic phases across a library of natural 
isolates from the model biofilm-forming bacterium Pseudomonas aeruginosa.  Under 
our model, we generally expect strains with low growth rates to tend towards higher 
rates of colonization, those with intermediate growth rates to favor intermediate rates 
of colonization, and the fastest growing strains to have the lowest rates of 
colonization; this negative relationship between r and c leads to a hump shape when 
biofilm cells are plotted against planktonic cells, indicating total biofilm is maximized 
at high (but not extreme) growth rates and low colonization rates (Figure 2.4B).  We 
found that allocation within our P. aeruginosa isolate library tended to follow this 
pattern as well (Figure 2.4C), with a regression of biofilm cells onto a negative 
quadratic in planktonic cells being highly significant (B = 0.62*P – 0.49*P2, with 
standard errors of 0.07 (p = 2.13*10-15) and 0.06 (p = 2.65*10-13) for the linear and 
quadratic predictors, respectively). 
  
2.4.4 Biofilm as a bet hedge against environmental instability 
36 
 
In our evolutionary model (Figure 2.3), we assume that lineages can adapt their 
allocation decision making (c*) in the context of constant transmission weightings kp 
and kb.  However, the relative success of biofilm vs. planktonic cell propagules is 
likely to vary extensively in time as a function of unpredictable biotic and abiotic 
stresses (i.e. changing kp relative to kb).  The nature of the relationship between the 
biofilm and planktonic populations as the colonization rate changes (Figure 2.4A) 
indicates that the biofilm compartment has the potential to function as a relatively 
cost-effective bet hedge against changes in the environment within and/or between 
patches.  At all growth rates, populations can exchange a small reduction in the size 
of the planktonic population for a massive increase in the biofilm population by 
raising the rate of colonization from a minimal value: returning to Equations 1.1 and 




which approaches infinity as c approaches r.   
It is therefore relatively cheap for populations to maintain a small but reasonably 
robust biofilm presence, while still devoting the vast majority of cellular resources to 
the immediately productive planktonic phase.  This result suggests selection would 
be unlikely to purge biofilm altogether, and simple passaging experiments show that 
even when only the planktonic fraction is transmitted, biofilm is still maintained after 
20 transfers (Figure 2.5).  Ancova of fraction biofilm after the initial period of 
divergence (i.e. starting from passage 7) found a reduction of 0.47 (from the intercept 
of 0.59 in the biofilm-passaged lines) when the planktonic fraction is transferred 
(SE=0.02, p < 2*10-16), and a small but significant decline in fraction biofilm with 
continued passaging when biofilm was transferred (-0.007 per passage, SE=0.001, p = 
5.8*10-13) but not when the plankton were transferred (estimate for interaction 
between planktonic transfer and passage of 0.009 (SE=0.001, p = 1.9*10-11), negating 
the effect in the biofilm-selected lines).  This gradual decline in fraction biofilm in 
biofilm-passaged lines is due to the planktonic fraction expanding relative to the 
biofilm fraction over the course of the experiment (see Figure S3.1; ancova of OD over 
passage, selection regime and fraction measured; increase of 0.01 OD units / passage 
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in planktonic OD relative to biofilm OD when biofilm cells are passaged, SE = 0.0005, 
p < 2*10-16), consistent with the findings of our evolutionary model. 
 
Figure 2.5:  Selection for planktonic transmission fails to purge biofilm from 
experimental populations.  P. aeruginosa (PAO1) was grown in 96-well plates 
containing a glass bead at room temperature, and every 12 hours populations were 
fractionated, measured, and passaged to a new well.  Fraction biofilm is defined as 
the ratio of the biofilm OD to the sum of the ODs of the two fractions.  Points represent 
12 independently evolving lineages per treatment. 
 
   
The low cost of maintaining biofilm makes it well suited as a potential bet-hedging 
strategy, trading instantaneous mean fitness to increase the long-term geometric 
mean fitness in unpredictable environments by reducing the variance in fitness 
through time.  To test this prediction, we used our model framework to construct a 
simulated passaging regime in which growth and transmission parameters were 
subject to differing levels of variance.  We assigned inoculum populations of 
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planktonic cells a fixed colonization rate c (applied relative to r), which were then 
subjected to alternating periods of growth and transmission. Parameters r, t, kp and kb 
were drawn from normal distributions with fixed means µ, and differing variances 
σ2 between treatments.  The values for r, t and c were used to solve Equations 2.1 and 
2.2; proportions kp and kb of these new cells were then passaged to the next growth 
phase, as in Equation 3.1.  R0 (Frank, 1996) was used as our fitness metric for these 
simulations, calculated as the ratio of founding cells in a given passage relative to the 
number of founding cells in the previous passage.  Simulation results are displayed 
in Figure 2.6. 
 
  
Figure 2.6:  Increased colonization maximizes geometric mean fitness under 
unpredictable conditions.  Log-scale plots of A, Average R0 across passages, and B, 
geometric mean of R0, are plotted as a function of relative colonization rate for 
lineages subject to passaging simulations with different levels of environmental 
instability.  100 replicate inocula of 5000 planktonic cells with the same fixed 
colonization rates c ∈ [0,0.2] were subjected to 10 passages.  For all cases, µr = 0.06, µt 
= 40, µkp = 0.1 and µkb = 0.6.  Under fixed conditions these parameters would favor c* 
= 0.49.  Variance treatments modified σ2 of the distributions from which r, t, kp and kb 
were drawn, with σ2low = µ/100, σ2mid = µ/9 and σ2high = µ/2.75.  Parameters were 
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restricted to logical values, with 0 ≤ kb , kp ≤ 1; r > 0; and t ≥ 1; this thresholding did not 
change the overall mean of any parameter by more than ±3%.  R0 was calculated as 
the ratio of founding cells at a given passage relative to the founding cells of the 
previous passage.  Points and error bars (offset to reduce overlap) represent averages 
with 95% confidence intervals, and solid lines display best-fit quadratic regressions 
(Table S2.1).   
 
For low and medium degrees of unpredictability, the average R0 declines 
monotonically in c, while with high unpredictability there is a pronounced hump in 
mean R0 (Figure 2.6A, Table S2.2), in agreement with our hypothesis that biofilm may 
function as a bet hedge.  This is also reflected in the geometric mean of R0 across the 
passaging simulation, where all treatments show a significant hump shape (Figure 
2.6B, Table S2.2), indicating the increased risk of extinction if sufficient biofilm 
investment is not maintained, even for relatively low levels of unpredictability. 
Interestingly, our simulations found that the colonization rate maximizing geometric 
mean fitness (c/r at roughly 0.1) is lower than the corresponding c* in the static 
condition, and that average and geometric mean fitness is maximized under the 
greatest degree of unpredictability (red lines, Figure 2.6).  Together, these findings 
suggest an asymmetry in the costs and benefits associated with assuming risk under 
unpredictable conditions.  A moderate reduction in colonization rate can increase 
fitness by more fully leveraging the planktonic growth engine, the benefits of which 
outweigh the small increase in assumed risk (as suggested by the gradual decline in 
biofilm allocation even under biofilm selection in Figure 2.5).  However, reducing the 
colonization rate too drastically eventually results in extinction risks that overcome 
the net benefit (as in Figure 2.6), suggesting an optimum minimal level of biofilm 
investment that maximizes growth but may still survive extreme environmental 
perturbations.  
2.5 Discussion 
In this work, we constructed a simple deterministic model of allocation between the 
coupled biofilm and planktonic compartments within a growing bacterial 
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population.  Within the biofilm, cell division limited by geometry and nutrient 
diffusion rendered its effects inconsequential to the dynamics of the population as a 
whole, relative to the exponentially expanding pool of planktonic cells.  Under 
inhospitable conditions, in which the population experienced restricted growth 
and/or frequent disruption, trade-offs between the biofilm and the planktonic 
compartment forced lineages to specialize in whichever fraction was favored to 
transmit between patches.  When conditions become more permissive, the lineage is 
able to leverage exponential planktonic growth to maintain robust populations in 
both compartments, and at a fraction of the cellular cost of initial biofilm allocation 
(i.e. at reduced colonization rates c); in general, such cost saving measures are likely 
to be favored in any cooperative trait during periods of growth (Cornforth et al., 2012).  
Because maintenance of a biofilm comes at little cost under conditions favoring 
planktonic growth, biofilm is able to function as a robust and cost-effective bet hedge 
against changing environments.  Conversely, the planktonic fraction is a useful 
amplifier of biofilm cells even when biofilm is the transmissible propagule – this 
growth/transmission division of labor is more obvious for strictly non-growing 
phenotypes (e.g. spores), but the same logic holds for slow growth in biofilms as well.  
We focus primarily on biofilm-planktonic cell populations as a model of survival-
fecundity alternate states, and therefore use the language of colonization (of biofilms 
by planktonic cells) and dispersal (from the biofilm) to represent the switching 
processes between the two phenotypes. However, the model logic applies to other 
classes of resistant cells as well, such as persisters and spores.  Indeed, there are 
instances where biofilm formation functions as a prerequisite or amplifying step in 
the formation of other types of resistant cells: persister cells are often enriched in 
biofilms (Singh et al., 2009; Lewis, 2010; Nadell et al., 2009; Haaber et al., 2012; Høiby 
et al., 2010a), and biofilm formation is a prerequisite step in fruiting body formation 
(the preferential site of sporulation) in Bacillus subtilis (Branda et al., 2001; Aguilar et 
al., 2010); it would be interesting to investigate how investment would be optimized 
with multiple phenotypes available in both simultaneous and sequential contexts. 
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Given the costs inherent to cellular investment into a growth-limited state, one may 
expect lineages to evolve the ability to efficiently switch between biofilm and 
planktonic phenotypes, thereby optimizing fitness by reducing lag times and 
minimizing unnecessary mortality in the event of environmental disturbance, and 
indeed such systems appear to be abundant in nature (Schuster et al., 2013; Cornforth 
et al., 2014; Barraud et al., 2009; Huynh et al., 2012; Dow et al., 2003; Sauer et al., 2004).  
However, we note that phenotypic switching in this case would not supplant the need 
to maintain some level of biofilm as a bet hedge (Figure 2.5, Figure 2.6), but rather to 
enhance the efficiency of such maintenance; in environments where catastrophic 
disturbances occur even at very low frequency, lineages that maintain biofilm 
regardless will still have better chances of survival.  One would therefore predict 
biofilm to be completely lost in only the most constant environments (Figure 2.5). 
Phenotypic regulation to further optimize allocation between biofilm and planktonic 
lifestyles would also help expedite the evolution of rudimentary life cycles at the 
population level, alternating between a growing ‘soma’ and dispersive ‘propagules’ 
with distinct demographies associated with each phase.  Under the formalism 
presented here, either the biofilm or planktonic compartments alone, or some 
combination thereof, may serve as either stage of the life cycle.   
The historical archetype has generally held that the biofilm functions as the soma, 
with motile planktonic cells as dispersive propagules (O’Toole et al., 2000; Sauer et al., 
2002; Monds and O’Toole, 2009); more recently Hammerschmidt et al. (2014) found 
that alternating selection on dispersive and biofilm phenotypes in Pseudomonas 
fluorescens leads to the evolution of a lifestyle in which cooperative biofilm cells 
producing shared adhesive molecules form a pellicle that functions as the growing 
soma, and planktonic non-adhesive cheats are co-opted as dispersive propagules, 
thereby dividing labor between the two cellular fractions and increasing the overall 
fitness of the lineage. 
Our results indicate that the opposite cycle (biofilm cells as propagules, planktonic 
cells as soma) could also be viable, as the population can still reap the benefits of 
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dividing labor between specialized cellular fractions.  Indeed, where individual 
patches are permissive to growth, but transmission between patches is exceedingly 
harsh (e.g. wind- or animal-dispersal), dispersal via biofilm aggregates and growth 
within a planktonic ‘soma’ would offer the greatest advantage, as the ‘soma’ would 
accumulate biomass rapidly, and dispersal propagules would enjoy increased 
survival at little reproductive cost given the hostile transmission conditions.  For 
example, biofilm formation and other survival phenotypes are likely important to 
successful transmission via fomites, upon which bacteria can remain viable for 
months (Kramer et al., 2006).  Dispersal in physically linked groups (i.e. budding 
dispersal, (Kümmerli et al., 2009a)) may also help maintain cooperative traits during 
dispersal, thereby potentially accelerating colonization when a new patch is reached.  
The biofilm ‘streamers’ observed by Drescher et al. (2013) may be another example of 
this mode of transmission, where flow rates are such that the biofilm forms physical 
bridges to allow colonization of vacant surfaces in a topographically complex 
environment, as full detachment would prevent recolonization of adjacent surfaces 
due to extreme shear forces. 
Taken together, our results highlight the evolutionary significance of within-
population phenotypic heterogeneity and its consequences for survival and fecundity 
in mixed transmission environments.  By optimizing the switching rate between 
robust and fecund specialists (here, the colonization rate from the planktonic to 
biofilm fractions, though we note that other mechanisms could lead to equivalent 
outcomes, such as the steady-state frequencies of genotypes arising from within-
population diversification, as in (Poltak and Cooper, 2010)), lineages were able to 
maximize fitness and transmission across a wide range of environments, as well as 
enhance survival in the face of catastrophic changes within the environment.  The 
rate of phenotypic switching is therefore an essential parameter upon which selection 
may act when multiple phenotypes can persist within lineages, and given the breadth 
of environmental parameters investigated here, we posit that the conditions dictating 









 ) may hold quite generally.  
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2.6 Supplemental Material 
2.6.1 Supplemental Data 
 
 
Supplemental Figure 2.1: Comparison of full and simplified models.  A and B, 
schematics of the full and reduced models, respectively.  C, Numerical simulations 
comparing the full and reduced models.  Simulations evolved for 50 time steps, with 
B0 = 0, P0 = 5,000,000, 0.02 ≤ r ≤ 0.1 (blue-red color scale).  For the full model, d = 0.01 
and g = 40,000 (as a linear rate); the reduced model sets d = g = 0.  Overall dynamics 
are quite similar; in general, the reduced model tends to underestimate cells in the 
planktonic fraction at high colonization rates (and more so at high growth rates), and 
to a lesser extent underestimate cells in the biofilm at low colonization rates (more so 






Supplemental Figure S2.2:  Optimal colonization rate c* as a function of 
reproductive value for planktonic and biofilm cells.  c*/r is plotted under the same 
conditions as in Figure 2.3, but panels vary growth period as opposed to growth rate 
(here r = 0.08), increasing from left (t = 10) to right (t = 70). 
 
 
Table S2.1: Regression models for bet-hedging simulations (see Figure 2.6).  
Parameter estimates for models displayed in Figure 2.6.  Linear and quadratic 
regressions were fit and compared for each variance treatment, and the best model 
chosen on the basis of lower AIC (Akaike, 1981); this was the quadratic regression in 
all cases except the average R0 under low variance, where the linear model was the 






log[Average R0] low Intercept 0.17 0.01 < 2E-16
c -0.19 0.04 2.05E-06
mid Intercept 0.63 0.03 < 2E-16
c -3.84 0.80 1.82E-06
c 2 11.95 3.86 0.002
high Intercept 1.06 0.17 4.52E-10
c 7.35 3.94 0.06
c 2 -46.0 19.0 0.015
log[Geometric low Intercept 0.12 0.01 < 2E-16
Mean R0] c 0.39 0.13 3.20E-03
c 2 -2.26 0.63 3.80E-04
mid Intercept 0.06 0.02 0.001
c 2.04 0.46 8.60E-06
c 2 -8.31 2.19 1.60E-04
high Intercept 0.11 0.04 3.69E-03
c 2.60 0.87 2.91E-03




2.6.2 Supplemental Derivations 
 
2.6.2.1 Derivation for Equation 2.3 
Combining equations 2.1 and 2.2 yields 
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2.6.2.2 Derivation of Equation 3.3 
Our fitness function is defined as 
𝑊(𝑐, 𝑟, 𝑡) =  𝑘𝑝𝑒
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3   Genetic evolution of phenotypic antibiotic 
resistance 
 
Nicholas Lowery & Sam P. Brown 
 
3.1 Abstract 
Biofilm formation is a virtually ubiquitous growth phenotype available to microbes 
in both natural and clinical settings.  Biofilms are relatively recalcitrant, and thought 
to contribute to the failure of antibiotic treatments in clearing microbial infections by 
providing resistance towards the antibiotic in otherwise genetically susceptible cells, 
which we define as ‘biofilm resistance’.  By experimentally evolving the opportunistic 
pathogen Pseudomonas aeruginosa under antibiotic exposure and monitoring the 
relative investment of cellular resources to the biofilm, we found preliminary 
evidence suggesting that biofilm resistance is evolutionarily labile, and can be 
strongly induced in a cost-dependent manner, as dictated by the antibiotic profile and 
transmission bias towards or against biofilm cells.  Some evidence also tentatively 
indicates that biofilm resistance may facilitate evolution of genetic resistance 
mutants; however, this and other observations require validation via further 
sequencing and phenotypic analysis.   
3.2 Introduction 
We currently face a crisis in antibiotic resistance, with resistant bacterial infections 
increasing in frequency and few leads on new drugs to combat them.  Classic 
resistance is achieved through genetic modifications that directly impact drug 
efficacy, such as alteration of drug targets, direct degradation of antibiotics, or 
prevention of drug entry into the cell (Blair et al., 2014).  However, bacteria can also 
resist antibiotic killing by inducing physiological changes in the absence of genetic 
mutation, providing ‘phenotypic resistance’ (Wiuff et al., 2005; Corona and Martinez, 
2013) to antibiotics.  Phenotypic resistance can occur via diverse mechanisms, for 
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instance by formation of persister cells (Lewis, 2010), or forming multicellular 
biofilms (Høiby et al., 2010b; Van Acker et al., 2014; Gupta et al., 2013), and allows for 
otherwise genetically susceptible cells to persist under drug treatment, resulting in 
recurrent infections (Fauvart et al., 2011; Zhang et al., 2012), increased mutation pools 
from which genetic resistance can evolve (Cohen et al., 2013), and decreasing effective 
drug doses potentially accelerating genetic resistance evolution (Høiby et al., 2010b; 
Greulich et al., 2012). 
In this work, we are primarily concerned with phenotypic resistance mediated by 
biofilm formation, hereafter referred to as ‘biofilm resistance’ (Figure 3.1).  Because 
biofilm formation provides resistance to multiple threats and can have profound 
effects on the overall growth of a population (see Chapter 2), it is often plastically 
regulated and responsive to multiple environmental cues.  For example, biofilm 
formation in P. aeruginosa, a widespread biofilm model organism, rapidly responds 
to quorum sensing signals (de Kievit, 2009), changes in the nutrient environment 
(Huynh et al., 2012; Sauer et al., 2004; McDougald et al., 2011), and cues from 
conspecifics (Bragonzi et al., 2012; Oliveira et al., 2015); notably, biofilm formation 
may also be induced in direct response to antibiotic damage (Cornforth and Foster, 
2013; Oliveira et al., 2015).  However, our previous work has also shown considerable 
genetic variation in the biofilm phenotype (Chapters 2 and 5), highlighting how such 
plastic responses can be genetically modified in response to selection; the relative 
contributions of plastic and evolved responses in biofilm and other tolerance 




Figure 3.1:  Schematic depiction of biofilm vs. genetic resistance.  Bacterial cells can 
exist in either the biofilm or the planktonic phenotypes.  Within these phenotypes, 
the population can be genetically susceptible (S) or resistant (R) to antibiotics.  Upon 
antibiotic exposure, susceptible planktonic cells die off, while resistant planktonic 
cells survive.  Conversely, biofilm cells survive due to resistance inherent to the 
biofilm phenotype, regardless of genotype; in this case, genetic and phenotypic 
resistance cannot be differentiated without further information, e.g. presence vs. 
absence of genetic resistance mutations. 
 
The tension between plastic and evolutionary responses are of critical importance to 
the evolution of resistance.  Theory suggests plasticity will limit evolutionary 
responses to smaller environmental changes by allowing individuals to respond 
appropriately in the absence of genetic mutation, while evolution will be accelerated 
when plasticity facilitates initial establishment and persistence in environments 
otherwise too extreme for colonization (West-Eberhard, 2003; Leggett et al., 2014).  In 
the context of antibiotic resistance, this implies that biofilm resistance mechanisms 
may either slow or accelerate evolution of genetic resistance mutants in a dose-
dependent manner.  Furthermore, it suggests that biofilm resistance will be an 
important bridge to genetic resistance when direct resistance loci are rare or 
inaccessible (a generally desirable characteristic for antimicrobial therapeutics). 
Evolution of genetic resistance mutants will likely create selective feedbacks onto 
biofilm resistance traits.  Given that biofilms and other tolerance phenotypes are 
generally slow growing (Yang et al., 2008; Tuomanen et al., 1986; Brauner et al., 2016), 
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previous theory suggests relaxing selection on phenotypically resistant cells will lead 
to rapid decline in the allocation of resources to that phenotype (Chapter 2), i.e. 
biofilm will likely decline upon evolution of faster-growing genetic resistance 
mutants.  However, even in the presence of genetically antibiotic resistance mutants, 
selection to maintain biofilm may persist due to damage accrued via competition with 
conspecifics (Cornforth and Foster, 2013; Oliveira et al., 2015) or the host immune 
system.  It therefore remains unclear regarding the effects of genetic resistance 
mutants on biofilm investment. 
We sought to experimentally investigate the dynamics of the interaction between 
biofilm and genetic resistance by monitoring the relative level of biofilm investment 
in evolving populations of the opportunistic pathogen Pseudomonas aeruginosa under 
varying types and doses of antibiotic.  Furthermore, we simultaneously imposed 
transmission requirements such that only biofilm or planktonic cells were transferred 
between passages, exaggerating the selective pressures acting for or against biofilm 
resistance.  A model schematic of the putative underlying process of population 
allocation and expectations for the experiment are summarized in Figure 3.2.  Based 
on our previous work in Chapter 2, we hypothesize that biofilm resistance will be 
evolutionarily labile (Figure 3.2C), and that the degree and direction of the 
evolutionary response will be sensitive to the environment (the antibiotic profile and 
B vs. P transmission).  Furthermore, we predict that biofilm resistance will facilitate 
evolution of genetic resistance, by providing a safe haven to a population of growing 




Figure 3.2:  Schematic of biofilm/plankton dynamics under antibiotic assault and 
predictions for experimental evolution.  A, Schematic of a bacterial population, 
comprised of surface-attached biofilm (B) and free-swimming planktonic cells (P) 
exposed to antibiotics, adapted from Chapter 2.  Cells can allocate into one of two 
compartments, the biofilm B or the plankton P. The relative abundances of B and P 
are controlled directly by the rates of colonization c and dispersal d, and indirectly by 
the growth rates r and g, with r >> g.  Treatment with antibiotic A inhibits growth in 
each fraction, to degree a1 or a2, respectively, and we postulate a2 > a1, i.e. the biofilm 
fraction provides some degree of resistance to the population.  We assume that the 
antibiotic has no direct effect on the rates of colonization or dispersal.  B and C, 
predictions for experimental outcomes for cases of purely plastic or mixed plastic and 
evolutionary responses.  Blue lines, no drug control; red lines, drug added; solid lines, 
biofilm fraction passaged (B-selected); dashed lines, planktonic fraction passaged (P-




We find preliminary evidence that biofilm resistance (as measured by relative biofilm 
investment) is indeed evolutionary labile, showing strong directional responses of 
both increasing and decreasing relative investment towards the biofilm, with the 
specific patterns dependent on the antibiotic and transmission environment.  In 
particular, we find that biofilm investment is maximal under biofilm transmission 
and intermediate drug doses, but that biofilm is also favored transiently under high 
drug doses regardless of passaging regime.  We suggest that in this latter case biofilm 
resistance is a stop-gap measure aiding survival, by providing a safe haven until a 
suitable genetic resistance mutant evolves.  This stop-gap model implies that the 
degree and duration of increasing biofilm resistance will be dictated by the frequency 
at which genetic resistance mutants arise.  By evolving populations under antibiotics 
with a loose hierarchy in accessibility of genetic resistance mutations, we observed 
patterns broadly consistent with this prediction.  However, further study, in 
particular obtaining genetic sequence information of the evolved isolates, will be 
necessary to help validate the largely phenotypic results presented here. 
3.3 Methods 
3.3.1 Passaging 
Populations of Pseudomonas aeruginosa PAO1 were grown statically in 200 uL of LB 
medium (with antibiotics, if appropriate; see below) in wells of 96 well plate with a 
single 3 mm sterile glass bead, at room temperature within a humidified chamber, 
and sealed with Aeraseal tape.  After each growth period (~10 hours), the planktonic 
fraction was transferred to a new plate and the OD(600) measured.  Biofilms (cells 
attached to the bead and walls of the well) were washed with sterile water via 
pipetting, then resuspended in 200 uL of fresh LB by sealing the plates with acetate 
tape and vortexing at 2000 rpm for 15 minutes.  The resuspended biofilm cells were 
then transferred to a new plate and the OD(600) measured.  Either biofilm or 
planktonic cells were transferred to a new plate with fresh media and antibiotics (see 
Figure 3.3).  An inoculum density of 0.01 OD units was used for the first three 
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passages, but this was relaxed to 0.05 for subsequent passaged to make bottlenecks 
less stringent. 
 
Figure 3.3:  Passaging procedure for selection experiment.  For each well, the biofilm 
(purple) and planktonic (green) fractions were separated and the OD(600) measured 
to estimate cell density in each fraction.  After density estimation, either the planktonic 
or the biofilm fraction was passaged to the next round, depending on the regime to 
which a given well had been assigned (represented by dashed line – only one of the 
two fractions was passaged for any single well).  Growth then allowed the 
populations to expand and differentiate, after which the process is repeated.  Glass 
beads present in all wells are omitted for clarity. 
 
3.3.2 Antibiotics 
Working stocks of rifampicin (from 50 mg/mL in methanol), tobramycin (10 mg/mL 
in water) and meropenem (10 mg/mL in water) were filter-sterilized and pre-
aliquoted to minimize freeze/thaw cycling that may affect activity during the 
passaging experiment.  MICs for each were determined by growing the ancestral 
PAO1 overnight in LB containing various concentrations of each antibiotic (Figure 
S3.3).  MICs were found to be 16 ug/mL for rifampicin, 2 ug/mL for tobramycin and 
4 ug/mL for meropenem; these concentrations were used as the baselines for the 




A factorial combination of 3 antibiotics (rifampicin, tobramycin, and meropenem – 
chosen because they represent a hierarchy in the availability of resistance mutations, 
see main text), at 8 doses (0, 1/32, 1/16, 1/8, ¼, ½, 1, 2X MIC for each drug), and across 
two passaging regimes (biofilm or planktonic cells transferred) were used, each with 
four replicates, totaling 192 independently evolving lineages. 
3.3.4 Data analysis 
For each lineage, regression models (as quadratic, linear or intercept models, chosen 
on the basis of minimizing AIC (Akaike, 1981)) were fit to the blank-corrected optical 
density readings for each fraction (i.e. biofilm and planktonic OD) for every lineage 
as a function of passage number.  Any negative values in the regression models were 
fixed at zero.  The data for figures and downstream analyses were drawn from the 
predicted values of the fitted models to dampen effects of noise (primarily due to 
temporal fluctuations in the duration of growth periods, which ranged from 8.5 to 




) over the 20 passages.  All statistical analyses were performed 
in R (R Core Team, 2015). 
3.4 Results 
3.4.1 No-drug control treatments 
We first consider the non-antibiotic control lines to examine the base effects of the 
passaging regimes (Figure 3.4 R1, T1, M1). Under each regime, we see strong evidence 
for evolutionary responses in biofilm investment, as the fraction biofilm (i.e. the 
proportion of total cells allocated to the biofilm) does not remain static with 
successive passaging.  In the planktonically-selected (P-selected, green) lines, we 
recover the expected result (based on previous theory in Chapter 2) of a rapid decline 
in the fraction of the population allocated to the biofilm to a low steady-state level.   
The B-selected lines (purple) also behave generally as expected from theoretical 
predictions, showing a mild increase followed by a gradual decline in biofilm.  An 
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increase in fraction biofilm when only biofilm cells are passaged is expected as cells 
adapt to the passaging environment, and our theory suggests the subsequent decline 
is due to the population relying on growth in the planktonic fraction for biofilm 
expansion rather than direct increases in colonization rates (Figure S3.1). 
3.4.2 Role of plasticity 
We can assess the extent of plastic tuning of the biofilm phenotype by examining how 
the degree of biofilm investment varies with increasing drug dose (Figure 3.5) after a 
single growth period.  Under the ‘damage sensing’ hypothesis (Cornforth and Foster, 
2013), one would expect the amount of biofilm to increase with antibiotic dose, up to 
some presumable limiting threshold.  However, we did not find support for biofilm 
allocation being an increasing function of dose (Figure 3.5A); instead, we found 
allocation to be unresponsive with low doses, declining at intermediate doses, then 
rising again at the high doses, a pattern that can be roughly approximated by a cubic 
function in dose (Figure 3.5B).  The specific antibiotics used did not have drastic 
effects on this overall trend, but tobramycin responded more robustly to increasing 
dose, while meropenem showed only minor changes.  This pattern suggests low 
antibiotic concentrations inhibit biofilm colonization and/or promote dispersal from 
the biofilm, up until some threshold dose is reached, but above which the more 
intuitive outcome of increased biofilm formation in the face of an environmental 
threat is restored.  This curious result requires further investigation, but is not of 






Figure 3.5:  Plastic responses in biofilm formation are inconsistent with a pure 
damage-sensing response.  A, Fraction biofilm is plotted for populations as a 
function of dose after a single growth period.  Points indicate averages of eight 
replicates (as the transfer regime has not yet been imposed), error bars the 95% 
confidence intervals, and curves the predicted results of the model in B.  Points are 
offset to reduce overlap.  B, Regression of fraction biofilm on log2-transformed dose.  
The maximal model was fitted as fraction biofilm as a function of antibiotic and a 
cubic in log2(dose) with all two-way interactions, and simplified via removal of 
insignificant terms to maximize parsimony.  Control treatments were modelled as the 
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next log-step down from the smallest antibiotic dose (i.e. log2(1/32) = -5, controls 
modelled as -6).  Log transformation also means the intercept values reflect biofilm 
fraction at the 1xMIC dose. 
 
 
We next ask whether and how plastic responses change during the course of 
evolution. Here the definitive experiments will involve the characterization of plastic 
responses to antibiotic challenge in intermediate and evolved clones. As a 
preliminary analysis, we focus on biofilm investment through evolutionary time 
(Figure 3.4). We predict that a purely plastic response to antibiotic challenge will be 
indicated by an initial period where biofilm fraction remains constant (i.e. is not 
influenced by the passaging regime), and this unresponsive period may be followed 
by a decline in fraction biofilm (due to a selective sweep by genetic resistance 
mutants) or continue for the duration of the experiment (in the absence of selective 
sweeps) (see Figure 3.2B).   
Under the working definition for purely plastic responses presented above, we find 
that biofilm remains roughly constant more frequently at high doses of antibiotic 
(Figure 3.4 R8, T8, M8), but also sporadically at lower doses (for instance, Figure 3.4 
R6, M2).  Plastic responses occurring more frequently with high dose is consistent 
with the model in which plasticity facilitates adaptation under extreme challenge 
(West-Eberhard, 2003; Leggett et al., 2014).  However, the apparent evolutionary 
response under control conditions (discussed above) makes it impossible to assess 
the relative impacts of plasticity in biofilm formation at lower doses without further 
phenotypic investigation.  In particular, it will be necessary to differentiate 
evolutionary responses to passaging and plastic responses to antibiotic treatment. 
3.4.3 Evolution of biofilm resistance 
Our model process indicates evolutionary adaptation in biofilm formation will 
manifest as sustained directional sweeps in fraction biofilm through time (Figure 
3.2C), with changes in direction a potential result of evolution of genetic resistance 
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mutants under antibiotic challenge.  We present evidence towards biofilm resistance 
evolution for each transfer regime in turn. 
3.4.2.1 Planktonic selection under antibiotics 
Under P-selection (Figure 3.4, green lines), when populations are exposed to 
antibiotics we observe clear evidence for the evolution of biofilm resistance as 
predicted in Figure 3.2C, with rapid directional changes in fraction biofilm through 
time.  The direction of this change is dictated primarily by dose: with low doses 
(Figure 3.4 R1-4, T1-4, M1-2), the trajectories mirror those of the control lines with a 
rapid decline to minimal biofilm.  With further increasing dose, however, we begin 
to see an increase in the fraction of the population allocated to the biofilm, in direct 
opposition to the effects of the base selection regime and indicating strong selective 
pressure for increased biofilm resistance.  The presence and magnitude of an increase 
in fraction biofilm under P-selection is influenced by the specific antibiotic, generally 
being stronger under meropenem and tobramycin treatment, and weaker with 
rifampicin (Figure 3.6 ACE). 
Figure 3.6:  Both genetic and biofilm resistance evolution are responsive to 
antibiotic profile and transmission regime.  The maximum in fraction biofilm 
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observed over the course of the experiment (A,C,E) and the fraction biofilm after 20 
passages (B,D,F) are plotted as a function of antibiotic (A,B, rifampicin; C,D, 
tobramycin; E,F, meropenem), dose (x-axis) and transmission regime (green, P-
selected; purple, B-selected).  Points indicate averages of four replicate lineages with 
95% CI error bars, and are offset to reduce overlap.   
 
The increases also generally appear to be transient, with a decline in fraction biofilm 
following the initial induction period, leading to a hump shape in the evolutionary 
trajectories (Figure 3.4 R8, T5-7, M5-7; also compare the maximum fraction biofilm 
with the fraction biofilm at the end of the experiment in the top and bottom rows of 
Figure 3.6).  Such abrupt transitions in the direction of the evolutionary response are 
consistent with the evolution of genetic resistance mutants changing the cost-benefit 
relationship of biofilm investment (Figure 3.2A).  Under the model process outlined 
in Figure 3.2A, genetic resistance mutants would effectively nullify the resistance 
asymmetry between B and P cells under antibiotic treatment (i.e., rendering a1 = a2 = 
0), and the direction of selection would therefore return to that as dictated solely by 
the transmission regime in the absence of drugs, in this case with a rapid decline in 
fraction biofilm (Figure 3.2C).   
3.4.2.2 B-selection under antibiotics 
When biofilm cells are passaged, we also observe changes in fraction biofilm 
consistent with evolution of increased biofilm resistance (Figure 3.4, purple lines).  
However, the pattern of the evolutionary trajectories shows a much stronger 
dependence on the specific antibiotic used, with tobramycin showing little response 
at all but the highest doses, while rifampicin and meropenem show more graded 
responses.   
The temporal dynamics of biofilm allocation are again broadly consistent with the 
predictions in Figure 3.2C, with relative biofilm investment increasing with 
successive passaging, and more so with increasing doses of antibiotics (Figure 3.4, 
Figure 3.6 ACE, possibly excluding the case for high-doses of rifampicin, discussed 
further below).  However, with antibiotic treatment it is less often the case that 
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increases in fraction biofilm are followed by a decline (as with the no-drug control 
lines); this is generally restricted to doses at or above 1x MIC.  This is expected given 
the differences in selection regimes – under P-selection, genetic mutants are able to 
exploit the fraction favored for transmission, and therefore genetic resistance mutants 
will enjoy a massive fitness benefit; conversely, B-selection favors transmission of 
mutants with enhanced biofilm resistance, thereby greatly reducing the fitness 
benefits associated with genetic resistance. One curious exception to this trend occurs 
at higher doses of meropenem under B-selection (Figure 3.4 M7; also potentially 
much less dramatically with rifampicin in Figure 3.4 R8), where the opposite 
transition occurs, with fraction biofilm initially plummeting, followed by a rapid 
increase.  This trend may reflect the action of meropenem reducing the efficacy of 
biofilm colonization, followed by an adaptation restoring colonization ability 
(unlikely, but see below), or may simply be an artifact of extremely low cell densities 
(Figure S3.2) – in either case, further investigation towards this anomaly is warranted. 
 
3.4.3 Conditions favoring phenotypic and/or genetic resistance 
We hypothesized that the conditions favoring biofilm resistance would be sensitive 
to environmental factors (B or P transmission routes, antibiotic dose) and also to the 
genetic details of resistance – in particular, the availability of resistance mutations 
and the fitness costs they impose.  
The antibiotics used in this study (rifampicin, tobramycin and meropenem) were 
chosen as they represent a hierarchy in the availability of resistance mutations.  
Rifampicin is expected to have a comparative abundance of available resistance 
mutations, as numerous SNPs can provide resistance (Qi et al., 2016).  Tobramycin 
requires multiple mutations to accumulate to confer appreciable resistance (El’Garch 
et al., 2007), making resistance to tobramycin less genetically available than rifampicin 
resistance.  Finally, meropenem is expected to be the most difficult target for 
resistance to evolve, as multiple specific mutations are required to confer resistance 
(Pai et al., 2001; Rodríguez-Martínez et al., 2009).  During the subsequent sequencing 
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and phenotypic characterization phase of this project, we will examine the evidence 
towards this hierarchy in our results. 
As an initial survey, we address which apparent resistance mechanisms are favored 
by examining the experimental outcomes for each treatment in turn. 
3.4.3.1 Rifampicin 
We expected rifampicin to be relatively easier to evolve genetic resistance 
mechanisms, and our experimental results are largely consistent with this, especially 
under P-selection.  Lines exposed to rifampicin showed the smallest relative 
investment towards the biofilm (Figure 3.6A).  Only under rifampicin treatment did 
P-selected lines universally display patterns consistent with evolving genetic 
resistance mechanisms (Figure 3.6B).  However, we also observed strong induction 
of biofilm resistance investment with rifampicin treatment (Figure 3.4 R2-6), and 
although biofilm investment is relatively low under B-selection with high doses of 
rifampicin (Figure 3.6A), the trajectories are not consistent with selective sweeps of 
genetic resistance mutants (Figure 3.4 R7-8, Figure 3.2C). 
Notably, rifampicin treatment was unique in that B- and P-selection showed sharply 
divergent outcomes in total growth (Figure 3.7A), with the total number of 
generations achieved under B-selection far exceeding P-selection treatments with 
increasing dose (nearly double at 2x MIC).  Indeed, under B-selection net growth 
increases by 2.2 generations with each increasing step in rifampicin dose (regression 
of generations on log2-transformed dose excluding control treatments; SE=0.22, 
p=3.56*10-10).  The combined results of low levels of biofilm investment and increased 
total growth suggest proliferation of more rapidly dividing genetic resistance 
mutants, but because the evolutionary trajectories in Figure 3.4 do not reflect this 
further work will be required to understand why larger doses of rifampicin accelerate 





Figure 3.7:  Growth advantage of P-selection diminishes with increasing antibiotic 
load and decreasing availability of resistance mutations.  Total growth over the 
course of the experiment (estimated generations) is plotted as a function of dose (A, 
rifampicin, B, tobramycin, C, meropenem) and selection treatment (green, P-selected, 
purple, B-selected).  Points display averages across four replicates in each treatment 




Tobramycin was expected to be a middle-ground in terms of ease of resistance 
evolution.  Consistent with this, we observed that tobramycin treatment induced 
greater allocation to the biofilm than rifampicin, but less than meropenem (Figure 
3.6C).  Additionally, under P-selection genetic resistance appears to readily evolve, 
but not to the highest dose (Figure 3.6D).  Unexpectedly, the responses to tobramycin 
were largely unaffected by dose (Figure 3.6CD; also Figure 3.7B, primarily under B-
selection); only at the highest concentrations (at least 1x MIC) was an appreciable 
effect observed (as an increase in the maximum fraction biofilm and a decline in final 
fraction biofilm).  Further investigation of the genetic changes accrued across doses 
of tobramycin will help to better discern the mechanisms of resistance – specifically, 
in attempts to differentiate whether 1) biofilm provides sufficient resistance to 
tobramycin, leading to a constant level of biofilm across low to intermediate doses; 2) 
if genetic resistance mechanisms evolved in a dose-dependent manner, and the 
fraction biofilm remaining constant is largely coincidental or a simple byproduct of 
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the passaging regime; or 3) if a single resistance mechanism evolved that imposed a 
dose-dependent cost, for example upregulation of an efflux pump with an upper 
threshold in the concentration of antibiotic it could mitigate.   
Interestingly, the evolutionary response to tobramycin also tentatively suggests that 
biofilm resistance may facilitate genetic resistance, in that the trends in final fraction 
biofilm between selection regimes appear to ‘cross’ between 1x and 2x MIC (Figure 
3.6E).  However, we note the high degree of variation between replicates at high doses 
makes it difficult to discern such general trends, and again genetic information may 
help to explain some of this variance; further passaging would also be of use to 
determine if it is indeed the case, as Figure 3.4 T8 suggests trajectories consistent with 
resistance evolution are much more common under B-selection.  Overall, these results 
suggest a closer balance between the costs of biofilm and genetic resistance pathways 
to tobramycin treatment, with biofilm resistance favored more broadly across both 
dose and selection regime, but with genetic resistance still often selected for. 
3.4.3.3 Meropenem 
We hypothesized that meropenem would be the most difficult drug for genetic 
resistance to evolve, due to its proposed two-step mechanism (Pai et al., 2001; 
Rodríguez-Martínez et al., 2009).  Our results were again consistent with this 
expectation, as meropenem treatment resulted in the greatest increase of biofilm, the 
least indication of genetic resistance, and the strongest response to increasing dose 
(Figure 3.6EF), and little evidence consistent with selective sweeps towards 
planktonic growth in the evolutionary trajectories (Figure 3.4 M2-8, with the possible 
exception of 1/4xMIC in Figure 3.4 M5); these observations will be corroborated with 
further phenotypic and sequence analysis.  With the apparent rarity of resistance 
mutations, we find that biofilm resistance is then of primary importance to growth 
and survival under meropenem, as evidenced by the strong increase in biofilm 
formation even under P-selection (Figure 3.6E) and the convergence of total growth 




3.4.4 Concluding remarks 
Considering these preliminary results of all treatment combinations, we propose the 
following working model for the evolution of biofilm resistance and its interaction 
with the evolution of genetic resistance mechanisms (Figure 3.8).  We expect biofilm 
resistance to be favored essentially whenever an antibiotic challenge is encountered.  
Whether such a response proliferates, resulting in an increase in investment towards 
the biofilm, will depend on the relative costs and benefits associated with genetic 
resistance.  If genetic resistance is relatively accessible (equivalently, for example, 
numerous mutation sites and low metabolic costs, or higher metabolic costs coupled 
with selection biased against biofilm resistance), it will evolve readily and proliferate 
within the population (Figure 3.8, blue line; similar to the case of rifampicin treatment 
and P-selection).  If genetic resistance is relatively inaccessible (influenced jointly by 
the rarity and cost of resistance mutations), the relative strength of selection 
(mediated by drug dose as well as whether the selective regime facilitates or 
antagonizes biofilm resistance) will determine whether genetic resistance evolves.  At 
low to intermediate selective pressures, the metabolic costs of genetic resistance 
prevent mutants from proliferating within the population, and biofilm resistance 
dominates (Figure 3.8, gold line; similar to the case of low dose rifampicin under B-
selection).  Under severe selection pressures, even mutants carrying extreme 
metabolic deficiencies will enjoy a reproductive benefit and proliferate, thereby 
reducing or eliminating the need for cellular allocation to biofilm resistance; here, 
biofilm resistance mutations will likely accumulate until a suitable genetic resistance 
mutant evolves (Figure 3.8, red line; similar to the case of high-dose tobramycin 
under P-selection, and potentially the case with meropenem treatment as well, where 
further passages my eventually yield genetic resistance mutants and a consequent 





Figure 3.8:  Biofilm resistance is maximized at intermediate selection pressure.  
Low cost resistance mutants quickly proliferate, reducing relative allocation to the 
biofilm within the population.  Higher cost mutants will tend towards biofilm 
resistance, with genetic resistance subsuming the phenotypic response when the 
antibiotic pressure is sufficiently severe.   
 
3.5 Discussion 
By monitoring the allocation of cellular resources within populations of P. aeruginosa 
experimentally evolved under various passaging and antibiotic treatment regimes, 
we found preliminary evidence suggesting that biofilm resistance can evolve much 
that same way direct genetic resistance mechanisms evolve.  Increasing biofilm 
resistance, as measured by allocation of cellular resources towards biofilm formation, 
showed dependence upon the specific costs of resistance in the environment: we 
found that it was favored under nearly all cases with B-selection, and at higher 
antibiotic dose with P-selection.  Furthermore, and especially so at high doses, 
increasing biofilm formation was often transient, followed by a relatively steep 
decline in biofilm.  This pattern is consistent with the evolution of genetic resistance 
mutants, which gain a fitness advantage due to their ability to better exploit the 
planktonic phase where more rapid cell division can occur.  Indeed, patterns in the 
dynamics of biofilm formation through time suggested the biofilm resistance may 
facilitate genetic resistance evolution – however, further phenotypic and sequencing 
66 
 
analysis is necessary to confirm observations relating to the evolution and spread of 
genetic resistance.   
Our data also suggest that induction of biofilm resistance is highly sensitive to the 
specific environmental conditions, with induction being more likely when biofilm 
cells provided reproductive value to the population at intermediate costs of antibiotic 
treatment, or at high cost of antibiotic treatment when planktonic cells were 
transmitted.  These results are broadly consistent with a model in which biofilm 
resistance is favored when the costs of genetic resistance mutations are inflated 
relative to the growth benefits they provide, which can arise either when the drug 
dose and transmission regime are such that genetic resistance provides little net 
reproductive benefit to the population, or when genetic resistance mutations are rare, 
in which case biofilm resistance mechanisms will proliferate transiently until a 
suitable genetic resistance mutant evolves and subsequently sweeps through the 
population. 
We observed that in response to antibiotic treatment, plastic phenotypic responses 
lead to declining biofilm formation with increasing dose, until an apparent threshold 
was reached, upon which it rebounded to levels on par with the no-drug control 
response.  Given that previous theory (Cornforth and Foster, 2013) and observation 
(Oliveira et al., 2015) have linked damage with increasing biofilm formation, we 
reason that our observations are due to higher overall concentrations of antibiotic 
being used.  For instance, rifampicin, shared in both studies experimental studies, 
was found to reduce biofilm formation quite severely at doses over 2 ug/mL in 
(Oliveira et al., 2015), which corresponds to the 1/8xMIC dose in this work.  Our 
results then indicate that plastic responses to antibiotic treatment may rebound at 
higher doses, suggesting either multiple regulatory mechanisms may govern this 
response, or alternatively that growth is suppressed severely enough to essentially 
prevent any plastic response.   
The apparent evolutionary tuning in the biofilm resistance response to antibiotics 
suggests this is an important part of the general resistance response to antibiotic 
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treatment.  That biofilm formation provides general resistance to non-antibiotic 
threats such as phages and immune effectors is particularly troubling, as it suggests 
evolutionary responses to any of these factors may increase resistance to all of them.  
This points to biofilm formation as a leading candidate for the development of so-
called ‘antibiotic adjuvants’ (Gill et al., 2014), which disrupt various cellular processes 
or phenotypes and thereby increase efficacy of co-administered antibiotics. 
We conclude by reiterating that these data report preliminary findings and are still 
awaiting validation via further sequencing and phenotypic analysis.  In particular, 
screening apparent genetic resistance mutants for increased MIC along with 
sequencing analysis will be crucial to validate and understand the dynamics of 
genetic resistance evolution in the context of simultaneous biofilm resistance 
evolution.  We will also seek to better understand the role of plasticity over 
evolutionary time by screening relative biofilm investment in evolved isolates under 
conditions different from those to which they have adapted (e.g. both higher and 
lower doses of antibiotics).   
However, we note that further study will be necessary to validate our observations.  
In particular, sequencing data will be essential to shed light on the mechanisms by 
which biofilm resistance evolves in response to antibiotic treatment, as well as to 
corroborate our observations on the timing of the evolution of genetic resistance 
mutants.  Phenotyping evolved isolates, in particular their allocation response in the 
absence of drug treatment, will also help to shed light on the nature of the plastic 





3.6 Supplemental Data 
 
 
Figure S3.1:  Accumulation of biofilm cells is driven by planktonic reproduction in 
the absence of antibiotic.  The ODs of each cellular fraction are plotted as a function 
of estimated generations (i.e. evolutionary time) under B-selection and in the absence 
of antibiotic.  In the first half of the experiment, biofilm increases while planktonic 







Figure S3.2: Population ODs through time (by passage, i.e. chronological time).  OD 
at the conclusion of each growth cycle is plotted as a function of passage number for 
each treatment combination.  The different populations are in each row, and columns 
denote antibiotics used.  Dose is indicated by color scale (blue, 0xMIC, red, 2xMIC), 
and dashed lines indicate P-selection, while solid lines indicate B-selection. 
 
 
Figure S3.3:  MIC determination of antibiotics used in this study.  PAO1 was grown 
for 24 hours in LB containing antibiotic, and the OD measured to estimate cell density.  
MICs were determined as 16 ug/mL for rifampicin, 2 ug/mL for tobramycin and 4 






4   Persistence is age-independent in E. coli 
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4.1 Abstract 
Bacterial persistence, in which a small subpopulation of bacterial cells shows a greatly 
reduced degree of killing by antibiotic treatment without any means of genetic 
resistance, has become increasingly recognized as a contributing factor to recalcitrant 
bacterial infections.  The low frequency of persister cells and apparent redundancy in 
genes associated with persistence has hampered attempts to understand the 
mechanisms governing their formation.  While important progress in this regard has 
been made, virtually all models of persister formation rely to some extent on 
stochastic metabolic disruption as the key progenitor leading to the focal cell 
becoming a persister.  Noting significant overlap between phenotypic markers of 
persistence and the markers of aging in bacteria, we hypothesized that persister 
formation may be deterministically influenced by the age of the individual cell, with 
older cells more likely to become persisters.  However, using FACS to sort E. coli cells 
based on a fluorescent marker of cellular age, we found no relationship between age 
and persistence when cells were exposed to varying doses of ampicillin.  
Nevertheless, we note that in general demographic determinants are a largely 
unexplored set of factors that may potentially influence persister formation, and may 
yet prove fruitful in our understanding of the causes of persistence and other 
phenotypes, especially as the techniques available to probe populations at the single-
cell level improve. 
4.2 Introduction 
4.2.1 Mechanisms of Persistence 
Bacterial persistence refers to the phenomenon by which a small subpopulation of 
cells survive treatment with antibiotics for a prolonged period of time, and in the 
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absence of any mechanism of genetic resistance (Figure 4.1).  Such cells are 
problematic, as they allow infectious bacteria to ‘wait out’ treatment regimes, then 
resume growth when the antibiotic has been removed, contributing to recurrent and 
recalcitrant infections, as well as increasing the mutational supply for the evolution 
of genetic resistance mechanisms (Lewis, 2010). 
 
 
Figure 4.1:  Biphasic death curves define persister cells.  Figure adapted from 
(Brauner et al., 2016).  Persistent cells show no differences in antibiotic resistance as 
measured by MIC testing, but display a characteristic biphasic death curve in which 
a small fraction of the original population persists for a prolonged period under 
antibiotic treatment. 
 
The mechanisms of persistence are beginning to be unraveled.  In general, it is 
thought that persistence occurs when a cell enters a transient dormant or slow-
growing state via stochastic metabolic dysregulation (Keren et al., 2004b), which can 
occur via several pathways.  Perhaps the best understood of these routes to 
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persistence is via induction of toxin-antitoxin (TA) modules.  Bacteria carrying TA 
modules produce two antagonistic compounds, a toxin and an anti-toxin.  In healthy 
cells, the toxin is neutralized by an antitoxin that is continually produced, protecting 
the cell from self-harm.  However, a transient drop in the labile antitoxin production 
allows the more stable toxin to become active, thereby forcing the cell into a 
metabolically stunted or inactive state; genetic manipulations of this system can 
induce orders of magnitude differences in levels of persistence (Lewis, 2010; Wood et 
al., 2013; Maisonneuve et al., 2013a). 
Bacterial stress responses have also been implicated in persistence.  In E. coli, when 
the stress response genes RelA and SpoT are induced via multiple stress pathways, 
the alarmone guanosine tetraphosphate (ppGpp) is produced (Gerdes et al., 2005), 
which goes on to induce further downstream stress regulators such as RpoS (among 
others), but has also been linked to the efficacy of cellular endotoxins and persistence 
in a number of systems (Aizenman et al., 1996; Korch et al., 2003; Amato and 
Brynildsen, 2014; Maisonneuve et al., 2013a).  However, because stress responses 
often act to temporarily slow or stop cellular division, the pathways and causal effects 
governing the formation of persister cells retain a high degree of redundancy, and the 
specific mechanisms and definitions differentiating stress from persistence are still 
being unraveled. 
4.2.2 A Role for Aging? 
While persistence was first noted shortly after the discovery of antibiotics (Bigger, 
1944), aging in bacteria was observed relatively recently.  Ackermann (2003) first 
observed a decline in the reproductive rate of asymmetrically dividing Caulobacter 
crescentus cells, where the stalked mother cells showed a gradual decline in the rate 
of reproductive events with each successive generation.  Shortly thereafter,  Stewart 
et al. (2005) observed a similar effect in symmetrically dividing E. coli cells.  In E. coli 
and all (roughly) symmetrically dividing organisms, the age of an individual is 
commonly conceptualized as the age of subcellular components, and can vary 
depending on whether a given component is created de novo or inherited from the 
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parent during the division cycle.  In Stewart et al., the authors focused on the age of 
the cell poles, with each daughter cell inheriting an ‘old pole’ and synthesizing a ‘new 
pole’ from the fission site.  As a colony grows, a distribution of pole ages naturally 
emerges, and Stewart et al. (2005) found that cells with older poles divided more 
slowly.  Further work showed that this aging effect correlated with the presence of 
insoluble protein aggregates which were primarily inherited along with the ‘old pole’ 
(Lindner et al., 2008).  In other experimental systems, aging E. coli cells were also more 
likely to induce stress responses such as SOS and filamentation (Wang et al., 2010).   
The significant overlap between phenotypes associated with persistence and aging 
(reduction in growth rate, induction of stress responses, increased protein 
aggregation (Leszczynska et al., 2013)) in bacteria led us to hypothesize that aging 
processes may have causal effects on the formation of persister cells, a result that has 
also been postulated from a theoretical standpoint (Klapper et al., 2007).  This would 
offer an alternative and deterministic explanation for the current understanding of 
stochastic formation of persister cells, in that persister cells could simply be the oldest 
subpopulation of cells, or more likely that the phenotypic switch governing persister 
formation is weighted by the age of the cell.  In any case, any indication of non-
random induction of the persister phenotype would be informative to further studies 
of the persister mechanism and towards methodologies to combat the clinical 
problems persisters present. 
We therefore sought to experimentally test whether aging, as defined by an 
intracellular aggregate marker (Lindner 2008), influenced levels of persistence in E. 
coli.  We found, however, that there was no difference in the frequency of persister 
cells in populations enriched in either old or young cells, in support of current models 
of stochastic induction of the persister phenotype. 
4.3 Methods 
To discriminate among age classes within a population, we utilized the MGAY strain 
of E. coli (Lindner et al., 2008), kindly provided by Ariel Lindner.  MGAY contains a 
YFP tag conjugated to IbpA, a protein which binds to and stabilizes protein 
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aggregates.  Because these aggregates accumulate and are preferentially inherited by 
the ‘old pole’ cells, the magnitude of the YFP signal correspondingly increases as cells 
age.  This fluorescent tag was used to segregate populations of old and young cells 
via FACS.   
For each of two independent replicate MGAY populations (grown to mid-exponential 
phase in 5mL LB broth), 500,000 candidate ‘old’ cells (brightest ~10% of the YFP 
distribution) and 500,000 candidate ‘young’ cells (dullest ~10%) were sorted into fresh 
LB medium in a 24-well plate.  These thresholds were chosen as they allowed for 
sufficiently large populations to be sorted in less time than a typical division cycle in 
E. coli (roughly 20 minutes), as any cell division will immediately begin to break down 
the stratification in age.  Each of the sorted populations was divided into nine 
replicate 200 uL aliquots in a 96 well plate.  A sample from each population was 
plated on LB agar to determine pre-treatment CFU, then LB containing ampicillin 
was added to a final concentration of 1, 10 or 100 ug/mL in each of 3 replicates, 
yielding 36 final populations (2 initial populations x 2 age treatments x 3 ampicillin 
doses x 3 replicates).  After one hour incubation at 37 °C with shaking, another sample 
was plated on LB agar to determine persister frequency.  All results are reported as 
fractional survival compared to the pre-treatment measures. 
4.4 Results 
We found no difference in persister frequencies in age-segregated subpopulations of 
E. coli (Figure 4.2).  No significant differences were detected between old and young 
cells overall or in a dose-dependent manner (Table 4.1), and similar results were 
obtained in a replicate experiment in which cells were exposed to a higher dose of 





Figure 4.2:  Persistence is age-independent.  No significant differences were 
detected between old and young cells after antibiotic treatment with regards to 
the fraction of surviving populations when plated on LB agar.  Antibiotic dose is 
indicated in the title of each panel, and the two replicate populations are indicated 
by filled vs. empty circles.  Points are individual replicates and lines indicate 
predicted values from model fit. 
 
Table 4.1:   GLMM of survival as a function of age and antibiotic treatment.  A 
generalized linear mixed model (GLMM) was fit to the fold change in survival across 
age class, dose, and their interaction (to test for dose-dependent effects) as fixed 
effects, and the replicate populations as a random effect.  A gamma error structure 
with the inverse link function was used to account for variance increasing with the 
estimate of the mean under a given condition; note the reported estimates must be 
back-transformed (inverted) to return the scale of the original data, as was done for 
Figure 4.2.  The intercept indicates the estimate for old cells exposed to 1 ug/ul 
ampicillin, and the remaining estimates indicate deviations from the intercept.  




For age structure to have no effect on levels of persistence is surprising, as aging in E. 
coli leads directly to phenotypes associated with increased levels of persistence.  It 
may be the case that physiological effects due strictly to age are confounded with 
Fixed effects: Estimate SE p-value
(Intercept) 1.21 0.21 1.28E-08
young 0.25 0.24 0.308
dose10 0.38 0.26 0.139
dose100 41.76 5.66 1.62E-13
young:dose10 -0.40 0.37 0.28
young:dose100 -4.05 7.66 0.597
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other factors influencing persistence, for instance nutrient depletion and the 
accumulation of toxic byproducts from cellular division and metabolism, or 
accumulation of spontaneous mutants that occur with every division cycle and may 
affect persister frequency.  However, we attempted to minimize effects of 
environmental degradation in this experiment by keeping growth times short and 
cell densities relatively low (see Methods).  We also found that simple simulation 
models indicate that the evolution of mutant lineages predisposed to persistence 
would have a negligible effect on overall persister frequency at these time scales 
(Supplemental Data, Figure S4.2). 
4.5 Discussion 
The results of our experiment suggest that persistence is independent of age in E. coli, 
using protein aggregation as a marker for cellular age.  However, we limited this 
experiment to a single time point, and one of the hallmarks of the persister phenotype 
is a biphasic survival curve under antibiotic exposure (Keren et al., 2004a; Brauner et 
al., 2016).  We attempted to account for this by exposing age-stratified populations to 
varying doses of antibiotic, thereby manipulating the slope of the killing curve, but it 
may be the case that monitoring survival through time rather than dose may reveal 
more subtle effects of aging on tolerance that were not observed here.   
It may also be the case that our age stratification of the brightest ~10% of the original 
population was insufficiently stringent to detect age-dependent effects, but further 
purifying cells based on FACS methods may be difficult to achieve.  Narrowing the 
age spectrum (for instance to the oldest 1%) while maintaining sorting accuracy 
would come at the cost of either increased sorting time or decreased population sizes.  
Increasing the sort time will also increase the time that cells have to start growing 
before pre-treatment samples can be taken and antibiotics added, thereby disrupting 
the imposed age stratification.  On the other hand, decreasing the population size will 
increase the effects of noise in persister frequency; this could in turn be mitigated by 
increasing the number of replicates, but the problem of increased time before 
treatment again becomes the issue.  Our protocol was chosen in attempts to optimize 
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across these trade-offs in speed and accuracy, but it may be of interest to return to 
these experiments if improved FACS technology (or indeed alternative methods of 
cell sorting) become available. 
The MGAY strain of E. coli relies on protein aggregation as a correlate of age (Lindner 
2008), and our results indicate protein aggregation does not play a causal role in the 
formation of persister cells.  However, others have found a correlation between 
protein aggregation and persistence (Leszczynska et al., 2013) at stationary phase, 
suggesting that persistence may be induced by protein aggregates that do not 
associate with IbpA (the labelled protein of the MGAY strain), or alternatively that 
persistence is induced at a step upstream in the aggregation pathway, and other 
factors (such as growth phase, a major difference between this study and that of 
Leszczynska et al.) may determine whether aggregation does or does not correlate 
with persistence. 
Overall, this result agrees with the current hypothesis of stochastic metabolic 
dysregulation as the underlying mechanism of persister formation, as we failed to 
find any evidence for an effect of age on persister frequency.  However, this result 
does not preclude the effects of other demographic determinants of persistence, and 
whether or not persister formation is truly stochastic remains an open question.  The 
classic methodology for testing for lineage vs. stochastic effects would be a 
fluctuation test (Luria and Delbruck, 1943), but our models (Supplemental text, 
Figure S2) suggest such experiments would not be informative due to the inherently 
slow or non-existent growth rate of the phenotype of interest.  Nevertheless, tests for 
other demographic factors (e.g. cell size, other types of inclusion bodies, etc.) may yet 
provide new insights into the genetic and metabolic aspects contributing to levels of 
persistence in bacteria, especially as methods for analysis of microbial populations at 





4.6 Supplemental Data 
 
 
Figure S4.1:  Persistence is age independent.  Replicate experiments at a higher dose 
(200 ug/mL ampicillin) showed no effect of age on frequency of persistence (Welch 2-
sample t-test, t = 0.45, df = 3.23, p = 0.68).  In these experiments, the same protocol as 
in the methods was followed, except 100,000 cells were sorted into each candidate age 
fraction from four independent replicate MGAY populations. 
 
4.6.1 Supplemental Text:  Modelling predisposition to persistence 
Could de novo evolution of a mutant lineage with increased levels of persistence have 
an effect on the overall persister frequency of the population in our experiment?  If 
such a mutant were to have an appreciable effect on persister frequency, A) 
populations harboring mutant lines must have higher frequencies of persistence, and 
B) within populations harboring mutants, the frequency of persistence will correlate 
negatively with the time until the mutant appears, i.e. mutants appearing early on 
will generate more persister cells by the end of the experiment. 
To test our assumption that such a lineage would not have any effect on our 
experiments, we performed a simple individual-based simulation of a growing 
population of cells (Figure S4.2A).  Cells can have one of two genotypes: wild type 
dividing cells (G1), mutant dividing cells (G2).  At each time step, all growing cells 
(G1 and G2) divide, with the genotypes of the mother retained by the daughters.  
After division, each cell can then mutate and switch its genotypes, or switch its 
phenotype to a persister cell (P) which then remains dormant for the duration of the 
simulation.  G1 cells can become persisters at rate k1, or mutate to G2 cells at rate m; 
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G2 cells can become persister cells at rate k2, and we assume no reversion of mutants 
or persisters.  The results of the simulations are displayed in Figure S4.2. 
We found that populations in which no enhanced-persistence mutants arose actual 
had a small but significantly higher fraction of persisters (Figure S4.2B, Welch 2-
sample t-test, 95% CI for difference in means = (5.65x10-7 – 6.08x10-6), p = 0.019), and 
in Figure S4.2C, we see that no correlation exists between the time it takes for mutants 
to evolve within the population and the fraction of persisters in the final population 
(95% CI for Pearson correlation coefficient = (-0.32, 0.17)).  We therefore conclude that 
our experimental assumption that de novo evolution will have a negligible effect 




Figure S4.2:  Individual based simulations of persister population dynamics.  100 
replicate simulations of the evolution of a mutant lineage with enhanced frequency 
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of persistence.  A, Model schematic.  B, Distribution of persister fractions across 
replicates, with blue bars indicating simulations where a G2 mutant evolved at some 
point, and red bars indicating cases in which no G2 mutants arose.  C, Time to G2 
mutant evolution as a predictor of persister fraction in the final population.  
Simulations were inoculated with 100 G1 cells, and allowed to grow for 12 
generations, with k1 = 10-5, k2 = 10-3 and m = 10-6.  The mutation rate was chosen to 
ensure mutants would evolve in a reasonable fraction of replicates, as the goal of 
these simulations is to determine whether such a mutant would be detectable in the 
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5.1 Abstract 
It is well established that different strains of the opportunistic pathogen P. aeruginosa 
can display impressive variation in clinically relevant phenotypes such as virulence 
factor production and antimicrobial resistance.  However, the extent to which this 
variation is constrained by environmental origin and tradeoffs among traits remains 
largely unexplored, especially so when considering strains isolated from outside the 
cystic fibrosis (CF) lung environment.  In this work, we seek to address this gap by 
surveying a broad suite of phenotypes related to growth, antibiotic resistance, biofilm 
formation and virulence factor production across a diverse library of 230 clinical and 
environmental isolates of P. aeruginosa, and ask to what extent higher-level 
organizing principles influence patterns of phenotypic expression?  We observed an 
impressive diversity across all phenotypes measured, with little evidence of 
dependency on environmental origin or tradeoffs among traits.  Strains sampled from 
the lung of CF patients illustrated the greatest phenotypic bias, with CF strains 
typically slower growing, forming biofilms containing more extracellular DNA, and 
preferentially expressing the siderophore pyochelin. However, environmental source 
only explains a small portion (much less than 25%) of total phenotypic variation.  
Ongoing genomic sequencing analysis will provide greater insights into the sources 
of phenotypic diversity across P. aeruginosa, including the ability to partition the role 
of phylogeny in shaping phenotypic diversity. 
5.2 Introduction 
Pseudomonas aeruginosa is an important nosocomial pathogen, imposing a growing 
health burden due to its environmental ubiquity, intrinsic resistance to antibiotic 
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treatment, and ability to form highly recalcitrant biofilms.  The domesticated lab 
strain, PAO1, is a popular model organism for studies of bacterial social behaviors 
(Diggle et al., 2007b, 2007a; Wilder et al., 2011; West et al., 2006), biofilm formation 
(Popat et al., 2012; Wei and Ma, 2013; Rice et al., 2009; Wang et al., 2014; Barraud et al., 
2009), and pathogenicity (Köhler et al., 2009; Rice et al., 2009; Jimenez et al., 2012; 
Rumbaugh et al., 2009).  P. aeruginosa also shows capacity for rich behavioral plasticity 
(Kümmerli et al., 2009b; Sauer et al., 2004; Huynh et al., 2012; Oliveira et al., 2015), and 
studies of both natural and laboratory isolates have indicated considerable 
phenotypic variation, for example with regards to antibiotic resistance (Darch et al., 
2015) and biofilm composition (Chew et al., 2014; Mann and Wozniak, 2012). 
The debate over the validity of lab strains representing natural isolates is an old one.  
It has generally been resolved by characterizing the lab strain for the phenotype of 
interest, then comparing the presence or absence of the trait in a sample of natural 
isolates of the same species.  However, this approach can run into issues where the 
lab strain does not express a relevant phenotype – for example, the lab strain PA14 
has lost several genes in the psl operon, an important matrix component (Mann and 
Wozniak, 2012).  This can force reliance on different strains for different phenotypes 
of interest, which may hinder comparative analyses and synthesis of experimental 
results due to genetic confounds among multiple ‘reference’ strains.  Furthermore, 
even when a reference strain possesses the requisite genes to express a given trait, 
plastic regulation may mask its expression, and comprehensive testing to generate 
reaction norms across environments is often prohibitive. 
Establishing organizing principals of phenotypic variation within a species is 
therefore necessary to effectively transfer knowledge gained in the lab to applications 
in the clinic and elsewhere.  This can be achieved by understanding the life history of 
the organism, and mapping observed patterns in phenotypes of interest to the 
evolutionary and ecological pressures that select for them.  Understanding the rules 
of how traits respond to varying selective pressures allows us to move from asking 
“what is the extent of observed variation?” to “what are the causes of observed 
83 
 
variation?”  By establishing how genetic and environmental factors influence 
evolution of a given phenotype, and in what direction, we gain greater predictive 
power.  The extent of plastic regulation in the trait is also an important component, 
as this can serve to buffer or accelerate adaptive evolution depending on the severity 
of the environmental perturbations experienced by a lineage (West-Eberhard, 2003). 
Here we aim to increase our understanding of the nature, causes and constraints on 
phenotypic diversity in P. aeruginosa.  We assess the extent of phenotypic variation in 
a broad suite of traits across a library of over 200 natural and clinical isolates of P. 
aeruginosa, and use the environmental origin of the isolates as a proxy to map 
phenotypes on to evolutionary history (in lieu of forthcoming genomic sequencing 
and phylogenetic information).  We find that P. aeruginosa varies widely in all of the 
phenotypes investigated here, and despite the limitations of our proxy for 
evolutionary history, uncover candidate evolutionary signatures in characteristics of 
growth, antibiotics resistance, biofilm formation and virulence factor secretion. 
5.3 Methods 
5.3.1 Strains 
The library of strains used here was kindly provided by Dr. Gabriel Perron (Bard 
College), see the Appendix for information on individual strains. 
5.3.2 Media 
Unless otherwise noted, all experiments were conducted in a rich defined medium 
(hereafter ‘growth medium’) consisting of M9 salts supplemented with 10 mM 
Glucose, 1% Cas-amino acids, 1mM MgSO4, 100uM CaCl2 and 1X Hutner’s trace 
elements (Hutner et al., 1950). 
5.3.3 Growth curves 
Mid-exponential phase starter cultures were used to inoculate each strain at an 
OD(600) of 0.05 into 150 uL growth medium in a single well of a 96 well plate, with 
tobramycin (2 ug/mL) or carbenicillin (32 ug/mL) as appropriate.  Plates were 
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incubated at 37 °C with shaking in a Varioskan plate reader, and the OD(600) 
measured hourly to track cell density. 
5.3.4 Biofilm allocation and composition 
Mid-exponential phase starter cultures were used to inoculate each strain at an 
OD(600) of 0.05 into 150 uL growth medium in a single well of a 96 well plate, which 
was incubated statically in a humidified 37 °C incubator for 6 hours.  This time point 
was chosen to minimize the effects of plastic regulation on biofilm formation, and 
better reflects the ‘hard-wired’ biofilm formation tendency of the strain.  After 
growth, the OD(600) of the planktonic phase was measured, and the bulk fluid 
removed via pipetting.  The biofilms were then washed by pipetting up and down 
with sterile water, then resuspended in 150 uL sterile 0.85% NaCl by adding 5-10 
sterile 1mm glass beads, sealing the plates with acetate tape and votexing for 15 
minutes at 2000 rpm.  The resuspended biofilm was then transferred to a new plate 
and the OD measured. 
The composition of the biofilm was assessed via two methods.  First, an aliquot of 50 
uL was taken for carbohydrate determination, as in (Masuko et al., 2005).  Briefly, in 
a 96-well plate 150 uL concentrated sulfuric acid is added to the 50 uL aliquot, 
followed by 30 uL 5% phenol in water.  The plate is then incubated at 90 °C by floating 
on a water bath for 5 minutes, then cooled to room temperature and the A(490) 
measured.  This absorbance is reported normalized to the OD(600) of the biofilm 
suspension measured above.  Note that this method measures total carbohydrates in 
the biofilm (including intracellular carbohydrates), so there may be some confounds 
due to variation between the intrinsic carbon content between strains, which is 
unknown.  However, these effects should be minimal as the cells were exposed to 
ideal growth conditions and restricted to relatively low cell densities, limiting the 
impact of starvation and other stress responses that directly impact carbon 
sequestration in the cell (Timmermans and Van Melderen, 2010). 
The remaining biofilm suspension was then subjected to live/dead staining via 
manufacturer’s specifications (Invitrogen).  Generally, live cells are measured via 
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green fluorescent dye Syto-9 (S9; ex/em 485/530 nm), while dead cells and 
extracellular DNA are measured via fluorescence of red-fluorescent propidium 
iodide (PI; ex/em 485/630 nm); both dyes intercolate with DNA.  Intact membranes 
block diffusion of PI into the cell, therefore live cells are primarily stained green, 
while PI outcompetes S9 when the two interact, meaning dead cells (with damaged 
membranes) and extracellular DNA stain red.  The fluorescence of each dye is then 
measured, and reported as normalized to the OD(600) of the resuspended biofilm. 
5.3.5 Virulence factor production 
Secretion of virulence factors is highly dependent on the growth phase of the culture.  
Due to asynchrony in the growth kinetics across isolates, we harvested supernatants 
for virulence factor secretion in groups based on when they were expected to enter 
late exponential phase from earlier growth curves (previous pilot data from our lab 
indicates this to be the peak point of secretion).  Cultures were grown in 150 uL of 
growth medium with shaking at 37 °C until the appropriate time, at which the 
OD(600) of the culture was measured. The culture was then transferred to a 1.5 mL 
tube and cells were pelleted by centrifugation at 14,000 rpm for 1 minute.  The 
supernatant was then collected and passed through a 0.22 um filter to obtain the cell-
free supernatant, and downstream analyses were performed immediately following 
collection. 
Pyochelin and pyoverdin production were measured via fluorescence of the 
supernatant aliquot as described in (Dumas et al., 2013).  Elastase production was 
quantified using the elastin-Congo red (ECR) assay (Ohman et al., 1980).  Briefly, 100 
uL of supernatant was added to 900 uL ECR buffer (100 mM Tris, 1 mM CaCl2, pH 
7.5) containing 20 mg ECR (Sigma), which was incubated with shaking for 20 hours 
at 37 °C.  Remaining insoluble ECR was pelleted via centrifugation for 1 minute at 
14,000 rpm, and 200 uL of supernatant was transferred to a 96 well plate and the 
absorbance at 495 nm measured.  Measurements for pyochelin, pyoverdin and 
elastase production are all reported as normalized to the OD(600) of the culture at 
time of harvest. 
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Pigment production was measured by taking a full absorbance spectrum (300-1000 
nm, bucketed by color: 300 < UV ≤ 380 nm, 380 < violet ≤ 450 nm, 450 < blue ≤ 495 nm, 
495 < green ≤ 570 nm, 570 < yellow ≤ 590 nm, 590 < orange ≤ 620 nm, 620 < red ≤ 750 
nm, 750 < IR < 1000 nm) of 150 uL cultures in growth medium after 48 hours 
incubation with shaking at 37 °C.  Absorbance readings were corrected by subtraction 
the absorbance values of a well containing sterile medium, then normalized in 
density by dividing the curves by the absorbance at 600 nm (the standard OD 
estimating cell density). 
5.3.6 Statistics 
All statistical analyses were performed in R (R Core Team, 2015).  Principal 
component analyses (PCAs) were visualized using the factoExtra package 
(Kassambara and Mundt, 2016). 
5.4 Results 
The strain library contains detailed meta-data on the source environment for each 
strain (see Appendix). We grouped isolates into three broad categories: samples from 
the lungs of cystic fibrosis patients (“CF”), samples associated with a host organism 
(including human, animals and plants; “host”), or non-host associated samples (e.g. 
soil, water, built environments; “env”), summarized in Table 5.1. 
 
Table 5.1:  Demographic breakdown of strain library. 
EVIRONMENTAL SOURCE NUMBER OF ISOLATES % OF TOTAL 
CYSTIC FIBROSIS (CF) 56 24 
HOST-ASSOCIATED (HOST) 106 46 
ENVIRONMENTAL (ENV) 68 30 





5.4.1 Growth and Antibiotic Resistance 
We grew each strain in a defined rich medium (see methods) for 48 hours, with no 
antibiotic or with the addition of carbenicillin or tobramycin.  Principal components 
analysis (PCA) showed good agreement between the parameters estimated for each 
growth curve (max growth rate, carrying capacity, and area under the curve (AUC), 
Figure S5.1), and AUC was chosen as the metric to describe growth under each 
condition (Figure 5.1). 
 
 
Figure 5.1:  Growth differs significantly based on environmental origin.  Left, AUC 
plotted as a function of treatment (control, carbenicillin, tobramycin) and 
environmental source (CF=cystic fibrosis, red; host=host-associated, yellow; 
env=environmental, blue).  Each point depicts an individual strain, and lines indicate 
within-source averages.  Right, results table of linear mixed model of AUC as a 
function of treatment and environmental source with interactions, and individual 
strain fitted as a random effect.  Intercept refers to CF isolates under control 
conditions, and estimates indicate deviations from the intercept. 
 
We found that isolates originating from CF lungs grew significantly slower than 
samples from environmental or host-associated sources, had greater relative 
resistance to tobramycin than other environmental sources, and curiously were more 
sensitive to carbenicillin (Figure 5.1).  We also note a large amount of variation 
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between isolates within each treatment block, indicating other important factors 
besides environment of origin dictate growth ability under a given condition. 
5.4.2 Biofilm Formation 
Biofilm formation is a key phenotype of P. aeruginosa, allowing populations to persist 
in harsh environments (see Chapters 2 and 3).  However, biofilm formation has also 
been associated with reduced virulence in other species (Otto, 2004; Mikonranta et al., 
2012).  We therefore sought to measure the relative propensities of each strain to form 
biofilm by measuring the relative allocation of cellular resources into the planktonic 
and biofilm fractions (Figure 5.2; note this is the same data presented in Chapter 2 







Figure 5.2:  Biofilm allocation follows a humped pattern across the strain library.  
OD of the resuspended biofilm is plotted as a function of the planktonic OD after 6 
hours of growth.  The curve represents regression of biofilm OD on planktonic OD 
with a quadratic term in planktonic OD (see main text), and marginal boxplots 
display breakdown of biofilm and planktonic ODs by environmental source (see 
Table 5.2). 
  
We previously developed theory (Chapter 2) that predicted a peak in biofilm density 
at intermediate planktonic density when comparing strains that varied in growth rate 
and biofilm colonization rates, which we recover in this strain library (regression of 
biofilm OD on planktonic OD gives B = 0.63*P – 0.49*P2, with respective standard 
errors (p-values) of 0.074 (3.1*10-15) and 0.064 (3.8*10-13) in the linear and quadratic 
predictors).  The rationale for this hump shape is that strains may take advantage of 
increased cellular division in the planktonic phase to indirectly drive expansion in 
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the biofilm (as opposed to directly increasing the colonization rate, which would lead 
to a strict negative relationship between the biofilm and planktonic population 
densities).   
 
Table 5.2:  CF isolates show reduced growth but greater relative investment to the 
biofilm.  Tukey’s Honest Significant Differences calculated from anovas of 
planktonic and biofilm ODs and fraction biofilm across environmental sources. 
 
 
If Figure 5.1 we observed that CF isolates generally grew more slowly and to lower 
carrying capacities than other strains.  Figure 5.2 reflects this finding, as CF isolates 
showed a marked reduction in planktonic density (average difference of roughly -0.2 
OD units, Table 5.2) and a minor decrease in biofilm density.  However, some CF 
strains still showed robust planktonic investment; these differences may reflect 
divergent strategies within the lung (e.g. hypervirulence vs. survival), or may simply 
be reflective on time spent in the CF lung with selection acting solely to reduce 
planktonic investment.  On average, though, we find that CF isolates generally have 
slightly higher levels of relative investment to biofilm (Figure 5.3D, Table 5.2), 
suggesting that biofilm formation is selected for as a survival / slow growth 
adaptation in the CF environment.  However, we also note that these differences do 
Planktonic OD
Difference Estimate p-value
env-CF 0.231 0.128 0.335 0.0000
host-CF 0.175 0.080 0.269 0.0001
host-env -0.057 -0.146 0.033 0.2942
Biofilm OD
Difference Estimate p-value
env-CF 0.029 0.000 0.059 0.0482
host-CF 0.043 0.016 0.070 0.0006
host-env 0.013 -0.012 0.039 0.4193
Fraction Biofilm
Difference Estimate p-value
env-CF -0.073 -0.113 -0.032 0.0001
host-CF -0.036 -0.074 0.001 0.0592






not explain the majority of variation in growth among isolates, and are of minor 
impact towards gross phenotypic patterning across the library. 
We further broke down biofilm phenotypes by measuring relative content of live 
cells, dead cells /extracellular DNA, and polysaccharides within the biofilm, and 
compared that to the relative investment of each strain towards the biofilm fraction 
(Figure 5.3).  Per-capita live cells correlated positively with strains that invested more 
in biofilm (Figure 5.3A, Table S5.1), while polysaccharide content correlated 
negatively (Figure 5.3C, Table S5.1).  These data suggest that strains favoring higher 
levels of biofilm investment are generally composed of more live cells and less matrix, 
a somewhat counterintuitive result when the matrix is viewed as the main component 
offering protection to the cellular inhabitants of the biofilm.  However, this does point 
towards a slow-growing but viable state as an important factor for the survival of 
biofilms following environmental challenge, as suggested previously (Høiby et al., 
2010b). 
Interestingly, the relationship between fraction biofilm and eDNA / dead cell content 
interacted significantly with environmental source (Figure 5.3B, Table S5.1), with 
higher levels of eDNA in CF isolates showing higher biofilm investment, and the 
opposite trend in host-associated and environmental strains.  This discrepancy may 
reflect the need for further increases in protection within the CF lung environment, 
potentially helping to compensate for less polysaccharides per capita, and points to 
apoptosis as an important mechanism of biofilm formation within that niche 





Figure 5.3:  Greater biofilm investment correlates with more live cells and less 
matrix.  Fraction biofilm (ratio of resuspended biofilm OD to sum of biofilm and 
planktonic OD) is plotted against A, live cell content, B, dead cell and eDNA content, 
C, polysaccharide content, and D, environmental source.  Each measurement for 
biofilm components is normalized to the OD of the resuspended biofilm.  Lines 
indicate regressions of fraction biofilm onto each component (see Table S5.1). 
 
5.4.3 Secreted Virulence Factors 
We measured the virulence capacity of each strain by assessing production of 
secreted virulence factors (VFs) elastase, pyoverdin and pyochelin.  Because these 
factors act as public goods, social ‘cheats’ (non-producers) can gain fitness 
advantages by not paying the cost of producing the molecules and simply using those 
secreted by neighboring ‘cooperative’ cells.  We can make a preliminary assessment 
of cheating strains by examining the distributions of VF secretion across the isolate 
library (Figure 5.4), where strains that produce little public goods relative to the 
population average are candidate cheating strains. 
The distribution of elastase production is consistently bimodal across all 
environmental sources, suggesting that elastase non-producing ‘cheat’ lineages are 
commonly found across environments. This pattern is consistent with the wide-
spread observation of quorum-sensing ‘cheat’ strains (particularly lasR mutants that 
are defective in signal response (Wilder et al., 2011; Allen et al., 2016)), which are 
defective in the production of an array of QS-controlled secreted factors including 
elastase.  Further work, in particular testing for enrichment of candidate cheats in co-
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culture with known producers, will be necessary to validate cheater phenotypes in 
any of the candidate cheat isolates. 
 
 
Figure 5.4:  Distributions of VF secretion levels suggest presence of elastase 
cheating strains.  Histograms show log-transformed measurements of elastase, 
pyoverdin and pyochelin secretions (normalized to culture density at time of harvest) 
broken down by environmental source and across the entire library.  Log 
transformations were performed to better differentiate strains producing low levels 
of secreted products. 
 
Noting the high degree of variability in VF secretion across the library (Figure 5.4), 
we asked whether patterns in VF secretion might reduce the dimensionality of our 
virulence metrics (Figure 5.5).  Aside from the siderophores pyocyanin and 
pyochelin, we found little evidence of correlation between any of the factors we 
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measured, nor meaningful differences between strains from different environmental 
sources.   
 
 
Figure 5.5:  Secreted virulence factors show little correlation with each other.  Each 
associated virulence metric is plotted against the others in the upper panels, with the 
Pearson correlation coefficient and significance indicators in the lower panels.   
 
The “V”-shaped pattern observed in production of the two iron-scavenging 
siderophores pyoverdin and pyochelin is intriguing, as it suggests two distinct 
groupings that preferentially secrete one of the two molecules.  PCA indicated that 
the first principle component primarily described overall siderophore production, 
while the second dictated which siderophore was preferred (Figure 5.6).  We found 
that CF isolates predominantly favored pyochelin, while environmental and host-
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associated isolated favored pyoverdin (Figure 5.6), based on the relative orientation 
of the confidence ellipses.  However, it should be noted that some isolates in each 
background of origin do not fall under this pattern, and it would be of interest to 
discern the causes behind such divergence. 
 
 
Figure 5.6:  Preferential siderophore production depends on environmental origin.  
Biplot of principal components analysis describing siderophore production shows 
PC1 (x-axis, 64.2% of variation) primarily describes the total amount of siderophore 
expressed, while PC2 (y-axis, 35.8% of variation) describes which siderophore is 
expressed, with positive values tending towards pyoverdin expression and negative 





Finally, it was noted over the course of the experiments that the strain library 
produced impressively diverse pigmented molecules (Figure 5.7A), and in P. 
aeruginosa such secreted products often function as virulence factors (the green color 
associated with pyoverdin production is perhaps the most familiar example).  We 
measured absorbance across the visible spectrum for a subset of the strain library at 
stationary phase, and compared absorbance at different wavelengths with our 
previous measures of secreted virulence factors via PCA (Figure 5.7BC). 
 
 
Figure 5.7:  PA isolates display extensive pigment variation.  A, pigment production 
from a sample of 47 strains from the isolate library after 48 hours growth.  “Blank” 
well containing sterile medium is in the top right corner.  B, PCA of absorbance across 
UV/visible spectrum and previously described secreted virulence factors.  Ellipses 
correspond to 95% confidence levels for each environmental origin (color scale).  C, 
Table displaying loadings of variables on first two principle components, 
corresponding to arrows in B.  Red indicates negative correlation, blue indicates 
positive correlation. 
 
Few guiding principles are apparent in the production of pigment molecules in our 
strain library.  The first principal component (Figure 5.7B, x-axis) explains the highest 
proportion of variance (46.5%) and primarily differentiates blue-green strains 
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(absorbing primarily red wavelengths, negative correlation with PC1) and red-brown 
strains (absorbing primarily blue-green wavelengths, positive values of PC1).  The 
second component indicates that specific virulence factors correlate weakly with 
pigment production, but no obvious relationships between coloration and molecules 
produced are apparent; testing an expanded catalogue of secreted products with 
known absorbance properties could help to identify putative matches, or 
alternatively by molecularly characterizing secreted products and looking for 
patterns across groups of strains of the same color.  We also found no evidence for 
significant differences between pigment production and environmental origin, based 
on the overlap of the confidence ellipses in Figure 5.7B, but this may in part be due to 
the reduced sample size, and bias within the sample towards host-derived strains. 
5.4.4 Correlations between phenotypic classes 
To investigate gross patterns in phenotypic covariation, we performed a PCA on the 
phenotypes of interest from each category discussed above (Figure 5.8).  We found a 
high degree of overlap persisted in differentiating strains by environmental source, 
but the first principal component (explaining 25.5% of the total variation) did weakly 
differentiate CF isolates from the others, mostly via characteristics previously 
discussed (e.g., higher proportional content of dead cells and eDNA in biofilms, 





Figure 5.8:  PCA reveals largely independent variation in most of the phenotypes 
considered.  Biplot of first two components (27% and 19.4% of total variation, 
respectively) from PCA of 13 phenotypic parameters (labelled arrows) across all 
strains in the isolate library (points).  Ellipses indicate 95% confidence levels for each 
group of environmental sources (color scale). 
 
Outside of differences due to environmental source, Figure 5.8 suggests a weak 
clustering between biofilm phenotypes (correlated positively with PC1) and growth-
associated phenotypes (correlated negatively with PC1), which is expected from the 
trade-offs between biofilm and planktonic cells.  However, PC1 only explains 25% of 
the total variation in the measured phenotypes, and the suggested trade-off is weak 
within those bounds.  In terms of overall patterning, we therefore conclude 1) a high 
degree of variation is observed in all of the traits measured across the library, 2) most 
of these dimensions are largely independent of one another, and 3) most traits are 




In this work, we screened numerous phenotypes relating to virulence across a diverse 
library of clinical and environmental isolates of the opportunistic pathogen P. 
aeruginosa.  Gross patterns in the data suggest few organizing principles relating 
phenotypes in growth, biofilm formation and virulence factor secretion.  Each trait 
showed a high degree of variability that was only weakly explained by 
environmental origin of the isolate.  Within this, however, we observed greater 
divergence in phenotypic signatures associated with isolates originating from the CF 
lung as compared to environmental or host-associated isolates; specifically, we found 
CF isolates to be slower growing, more sensitive to carbenicillin, resistant to 
tobramycin, to have increased eDNA content in the biofilm matrix, and to 
preferentially secrete pyochelin.  The extensive variation in all measured phenotypes 
suggests that behavioral plasticity has had little buffering effect on adaptive evolution 
within the library isolates.  This is not to say that we expect the isolates to have lost 
the capacity for plastic responses; rather, the phenotypic variation observed in this 
work under identical experimental conditions suggest considerable divergence in 
baseline expression levels and/or regulatory networks modulating all measured 
traits. 
The CF lung is potentially unique as an evolutionary niche for P. aeruginosa, in that 
lineages may persist in an infection context for decades; it is therefore unsurprising 
that CF isolates would show the greatest divergence compared to the other 
environmental sources.  Many of the traits we observed are adaptive in the CF lung: 
slow growth and eDNA in the biofilm matrix are both associated with general 
recalcitrance (Mulcahy et al., 2008; Høiby et al., 2010b), and tobramycin resistance will 
promote survival under treatment with this common CF therapeutic.  That CF isolates 
are relatively more sensitive to carbenicillin is unexpected, given that beta lactams 
including carbenicillin are routinely co-administered with aminoglycosides during 
CF treatment (Flume et al., 2009; Pleasants, 1994) - this suggests that CF isolates may 
lose or downregulate resistance mechanisms specific to beta-lactams in the CF lung 
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(potentially relying on resistance provided by other community members (Darch et 
al., 2015), or tolerance attributed to slower growth (Tuomanen et al., 1986; Yang et al., 
2008)), and more detailed study of the antibiotic resistance profiles across the library 
would be of interest. 
The bias of environmental origin on preferential siderophore secretion may reflect 
the relative abundance or iron in various environments.  The ability to switch 
between pyoverdin and pyocyanin has been suggested as a cost-saving mechanism 
in response to changes in relative iron availability in the environment (Dumas et al., 
2013), with the higher affinity but costlier pyoverdin being reserved for iron-limited 
conditions.  Iron is relatively abundant in the CF lung (Ghio et al., 2013), so CF isolates 
favoring pyochelin is consistent with the cost interpretation given in (Dumas et al., 
2013); however, this opens the question of why strains from other sources continue 
to secrete the more expensive pyoverdin when iron is less limited, as iron was 
relatively abundant in the media used in this experiment (roughly 18 uM).  It may be 
the case that these strains start producing pyoverdin late in the growth cycle as the 
iron concentration declines; alternatively, the ability to switch and/or the threshold at 
which switching occurs is evolutionarily labile in P. aeruginosa.  Further testing of 
growth and siderophore production under iron limitation would help to differentiate 
these outcomes.   
Importantly, we note that the environmental source of an isolate is not an ideal proxy 
for its evolutionary history, for two related reasons.  First, P. aeruginosa can disperse 
with relative ease between the sources considered here (e.g., an established CF isolate 
being coughed up and isolated from an environmental source), so it is a strong 
assumption that isolates taken from a given environment are in fact well adapted to 
that environment.  Second, comparing strains based on environment cannot control 
for phylogenetic correlations, i.e. we cannot account for the null expectation of 
genetically similar strains also being phenotypically similar. To this end, work is 
currently underway to sequence the genomes of all strains in our library, which will 
allow us to construct a phylogeny from which a more accurate model of evolutionary 
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history can be inferred, as well as attempt to associate genetic markers to observed 
phenotypic variants. 
Our finding that most of the measured phenotypes display little correlation with one 
another mirrors those of a recent investigation of morphologically identical P. 
aeruginosa isolates taken from a single CF patient (Darch et al., 2015).  Darch et al. also 
found little evidence for linkage between specific genetic mutations and measured 
phenotypes, instead finding phenotypes to be associated with regions of high 
recombination.  This will be an interesting benchmark for future work upon the 
completion of the sequencing mentioned above, allowing us to compare and contrast 
patterns of phenotypic and genetic diversity across scales (e.g., within-morphotype 





5.6 Supplemental Data 
 
 
Figure S5.1:  PCA of growth parameters.  High correlation was observed between 
max growth rate (max.rate), carrying capacity (max.od) and area under the curve 











Table S5.1:  Regression of fraction biofilm onto biofilm components.  Each model 
was originally fit with an interaction term between biofilm component and 
environmental source; this was only retained in the regression for dead cells + eDNA 




Fraction biofilm ~ live cells + source
Residuals:
Min 1Q Median 3Q Max
-0.195 -0.081 -0.005 0.070 0.304
Coefficients:
Estimate SE t value p-value
(Intercept) 0.240 0.024 9.85 < 2E-16 ***
live 1.38E-04 5.09E-05 2.72 0.0071 **
env -0.062 0.018 -3.53 0.0005 ***
host -0.029 0.016 -1.85 0.0658 .
Fraction biofilm ~ dead cells:source + source
Residuals:
Min 1Q Median 3Q Max
-0.181 -0.075 -0.007 0.068 0.254
Coefficients:
Estimate Std. Error t value Pr(>|t|)
(Intercept) 0.2468 0.0334 7.40 2.74E-12 ***
env 0.0464 0.0425 1.09 0.2759
host 0.0776 0.0389 2.00 0.0469 *
dead:cf 0.0003 0.0002 1.62 0.1063
dead:env -0.0005 0.0002 -2.88 0.0043 **
dead:host -0.0005 0.0001 -3.58 0.0004 ***
Fraction biofilm ~ polysaccharides + source
Residuals:
Min 1Q Median 3Q Max
-0.192 -0.074 -0.001 0.070 0.288
Coefficients:
Estimate Std. Error t value Pr(>|t|)
(Intercept) 0.399 0.024 16.83 < 2E-16 ***
polys -0.065 0.013 -5.01 1.11E-06 ***
env -0.080 0.017 -4.82 2.58E-06 ***
host -0.046 0.015 -3.01 0.0029 **
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6   Discussion 
6.1 Summary 
As the antimicrobial resistance crisis worsens, it becomes increasingly important to 
understand why treatment of susceptible populations fail, and how these failures 
may influence the evolution of genetic resistance mechanisms.  In many cases, 
treatment failure can result from the presence of heterogeneous phenotypes within 
the population that display reduced susceptibility to antibiotics, and while significant 
work has gone towards describing these phenotypes, their evolutionary and 
ecological dynamics remain poorly understood. 
In this work, we presented four experiments seeking to help fill this gap.  We found 
that biofilm investment, a widespread source of phenotypic resistance to antibiotics, 
is evolutionarily labile, and responsive to both transmission biases and antibiotic 
treatment (Chapters 2 and 3).  The canonical formulation of the biofilm ‘life cycle’ 
poses the biofilm as analogous to the soma and motile planktonic cells serve as 
dispersal propagules (O’Toole et al., 2000; Hall-Stoodley et al., 2004).  Our modelling 
and experimental results in Chapter 2 suggest that this conceptualization can be 
flipped on its head, with a mixed planktonic cells functioning as the growing soma, 
and biofilm cells as dispersal agents.  We also observed that biofilm can function as a 
cost-effective hedge against unpredictability within the environment, further 
expanding the range of conditions under which a mixed population is expected to 
persist. 
Our preliminary results in Chapter 3 show that relative investment towards biofilm 
formation is responsive to antibiotic treatments.  We observed patterns in the 
evolutionary trajectories that suggested biofilm-mediated phenotypic resistance may 
interact with conventional genetic resistance mechanisms, and in particular may form 
a bridge to genetic resistance; however, these observations are based on purely 
phenotypic data, and future sequencing analysis is required to properly test our 
predictions.   
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For persister cells, the genetic and physiological mechanisms of their formation are 
poorly understood, yet essential to understand the proximate and ultimate causes of 
their existence.  To this end, we hypothesized that cellular age may serve as a 
demographic determinant of the persister state, but found no evidence in support of 
this hypothesis.  However, we maintain that screening persister cells for other 
biochemical features at the single-cell level will be fruitful towards understanding 
how and why cells enter the persister state. 
Screening a diverse library of 230 natural isolates of P. aeruginosa, we observed a high 
degree of variation in multiple traits related to growth, antibiotic tolerance, biofilm 
formation, and secretion of virulence factors.  We observed that a handful of these 
phenotypes showed signatures depending on the environmental source of the isolate, 
such as slower growth and preferential secretion of the siderophore pyochelin in 
isolates originating from the lungs of patients with cystic fibrosis.  Together, our 
results indicate few organizing principles governing the extensive phenotypic 
variation in P. aeruginosa, suggesting many traits related to growth, survival and 
virulence can evolve relatively independently of one another.  However, the use of 
environmental source as a proxy for evolutionary history is problematic, and ongoing 
genomic sequencing will seek to address these limitations by replacing 
environmental source with phylogenetic relationships. 
6.2 Biofilms and Life Cycles 
A key theme in this thesis is the importance of understanding interactions among 
multiple phenotypic states, rather than focusing on the specific nature of each 
component phenotype separately.  Our results suggest that interactions – particularly 
transition rates - are evolutionary labile, and changes in these interactions can have 
important ecological and clinical consequences. 
Considering the interaction between biofilm and planktonic cells within a population, 
the historical paradigm suggests that biofilms function as the growing ‘soma’, and 
motile planktonic cells served as dispersal agents (O’Toole et al., 2000; Hall-Stoodley 
et al., 2004; Hammerschmidt et al., 2014; Poltak and Cooper, 2010).  We find the 
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opposite cycle to be favored under a broad range of environmental conditions, with 
biofilm as dispersal agent and a mixed population as the growing soma.  This 
conceptualization is consistent with the common observation that outside the 
laboratory microbes are most commonly found in biofilms regardless of environment 
(Costerton et al., 1987) – under our division of labor interpretation, this would imply 
that we commonly observe biofilms both during dispersal events and in preparation 
for dispersal, with planktonic cells utilized as a growth accelerant when conditions 
allow.  Biofilms provide several key benefits as dispersal, namely increased durability 
(Marks et al., 2014; Kramer et al., 2006), competitive advantages upon colonization 
(Kragh et al., 2016; Melaugh et al., 2016), resisting Allee effects (Smith et al., 2014), and 
maintenance of cooperation (Kümmerli et al., 2009a).  One exception to this rule could 
be when active motility is required for dispersal, for instance where patches are 
connected via static fluid channels and in the absence of suitable transmission vectors, 
though this could potentially be accomplished by biofilm cells as well via swarming 
motility (Kuchma et al., 2010; Anyan et al., 2014; Wang et al., 2014; Pollitt et al., 2015). 
Our results indicate biofilm investment is labile on both regulatory and evolutionary 
timescales, and the assumption that dispersal is primarily and robustly via biofilm 
(or planktonic) cells is strong. Previous work has identified planktonic cells as the key 
dispersal route (O’Toole et al., 2000; Hammerschmidt et al., 2014; Poltak and Cooper, 
2010), and by flagging biofilm dispersal as a viable transmission route it is not our 
intention to suggest that these routes are exclusive.  Indeed, our model in Chapter 2 
suggests mixed strategies are favored under a broad range of growth and 
transmission conditions.  This flexibility reflects a key difference between microbial 
and metazoan life histories, namely that microbial cells are not easily defined within 
a higher-order organizing unit or ‘body’ (Queller and Strassmann, 2009).  In this 
sense, microbial life histories may not respond in the same way to analogous 
pressures as the better studied cases of metazoan life histories, and it will be 
interesting to uncover the extent of these differences as the field of microbial ecology 
and evolution continues to grow. 
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In Chapter 3, we experimentally imposed distinct life cycles (strictly biofilm or strictly 
planktonic transmission) upon bacterial populations exposed to antibiotics, and 
found that biofilm investment was responsive in evolutionary time to antibiotic 
treatment.  The observed patterns also suggested phenotypic resistance mediated by 
biofilms may interact with genetic resistance mechanisms (pending further work 
discussed below), which may have broader implications for antibiotic control 
strategies.  Our imposed life cycles represent something of a worst case scenario from 
a clinical perspective towards antibiotic resistance, with lower antibiotic doses 
promoting prolonged survival under antibiotic exposure, and strong selection 
towards a phenotype that was clearly associated with a distinct mechanism of 
resistance (biofilm and phenotypic resistance, plankton and genetic resistance).  We 
hypothesize that infection contexts (both within a host and within the hospital 
environment) will largely select for increasing biofilm investment, due to the 
combined biofilm benefits of antibiotic resistance, resistance to immune effectors and 
chemical insult, and physical recalcitrance attributed to the extracellular matrix 
(Høiby et al., 2010b; Wei and Ma, 2013; Fux et al., 2005); our B-selection treatment is 
therefore likely a closer proxy to a ‘real world’ within-hospital transmission model.  
However, our experiment does not account for differences in the factors promoting 
selection towards increasing biofilm (e.g. antibiotic exposure alternating with 
desiccation and disinfectant treatment), and it would be interesting to test whether 
variation in selective forces changed the nature of the evolutionary response both in 
biofilm formation and genetic resistance mechanisms. 
6.3 Phenotypic heterogeneity and cellular condition 
The model described in Chapter 2 assumes that cells can switch stochastically 
between biofilm and planktonic phenotypes at defined rates c and d.  In Chapter 3, 
we introduce the possibility of environmental conditioning (i.e. plasticity) on the 
biofilm switching response, where cells may switch more frequently towards the 
biofilm in more damaging environments.  Under the ‘damage hypothesis’ model 
(Cornforth and Foster, 2013; Oliveira et al., 2015), biofilm investment is expected to 
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increase with greater accrual of damage.  Our results suggest that there may be 
thresholds in this response, as we observed declining biofilm investment with 
increasing antibiotic dose, but a rebound in biofilm formation at the highest doses. 
The damage hypothesis and biofilm formation are just one example of a broader link 
between environmental condition and internal state, which can often manifest as 
cellular damage.  In Chapter 4, we expand upon this link by hypothesizing that the 
persister phenotype also shows dependence upon cellular damage, specifically via 
accumulation of insoluble protein aggregates associated with cellular aging in E. coli.  
Our experiments suggest that persistence in E. coli is independent of the age structure 
of the population, but we concede that experimental limitations may have prevented 
testing this hypothesis definitively; given that the persister cells occur at such a low 
frequency, it may be the case that only the oldest 1% or even less of the population 
may display measurable differences in persister frequency. 
6.4 Phenotypic heterogeneity across broader environmental 
scales 
While the theory presented in Chapter 2 is quite general, the experimental studies in 
Chapters 3 and 4 respectively rely on two well-studied and highly domesticated lab-
strains of bacteria, P. aeruginosa PAO1 and a tagged variant of E. coli MG1655.  The 
use of laboratory-adapted reference strains offers many advantages, for instance in 
developing general protocols for experimental procedures, and facilitating 
comparisons of results generated in different studies.  However, reference strains also 
impose limitations, most notably in what can be inferred from a reference strain to 
the species it represents.  For instance, this can even manifest as differences in 
phenotypes between reference strains for the same species – P. aeruginosa serves as a 
popular model organism for biofilm formation, but PAO1 relies primarily on psl as 
the main polysaccharide component of the biofilm matrix, while the slightly more 
virulent reference strain PA14 produces more pel polysaccharide (Mann and 
Wozniak, 2012), and neither readily produces alginate to the extent of many mucoid 
isolates commonly found in the CF lung (Ciofu et al., 2010). 
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In Chapter 5, we examined the broader phenotypic diversity displayed by P. 
aeruginosa to explore just how representative PAO1 is towards a bacterial species 
known for behavioral diversity, and to ask whether such extraordinary phenotypic 
plasticity serves to buffer evolutionary change by allowing a single genotype to 
produce diverse phenotypes in response to widely varying environmental challenges 
(West-Eberhard, 2003).  In contrast with the ‘plasticity-buffers-evolution’ hypothesis, 
we observed considerable phenotypic variation across natural isolates within fixed 
experimental assay conditions, also indicating PAO1 is indeed a poor representative 
of the phenotypic diversity of which the species is capable.  Furthermore, our 
experimental results in Chapter 3 also suggest adaptive evolutionary responses 
overwhelm the effects of phenotypic plasticity in P. aeruginosa.  Together, Chapters 3 
and 5 point to an impressive evolvability and diversity of phenotypes across P. 
aeruginosa.  However, we note that these will require additional genomic sequencing 
analyses for a more comprehensive interpretation. 
6.5 Future work 
Completion of sequencing projects in Chapters 3 and 5 is an obvious first step in 
directions for future work.  In Chapter 3, this will allow for more precise 
determination of the dynamics of genetic resistance evolution, in particular towards 
answering our hypothesis that biofilm resistance facilitates the evolution of genetic 
resistance mutants.  Additional phenotyping to gauge the evolution of plasticity in 
the biofilm resistance response is also a key interest, as the evolutionary dynamics of 
plastic resistance responses to antibiotics are generally unknown, in addition to being 
generally informative about the role of plasticity in the generation and maintenance 
of diversity in P. aeruginosa, as discussed above. 
Genomic sequencing of the isolate library used in Chapter 5 will allow greater 
insights into the genomic and evolutionary determinants of the observed and 
dramatic phenotypic variation.  It will also facilitate comparisons of the genetic 
signatures of related phenotypes (biofilm, in particular) evolved ‘naturally’ in the CF 
lung and other environmental contexts from the isolate library, and experimentally 
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in Chapter 3.  Furthermore, a robust sequence-based phylogeny will allow us to 
explore the extent to which variation is shaped by evolutionary history, and also 
allow us to test comparative predictions with appropriate controls for common 
phylogenetic descent (Hadfield, 2010). For example, we are interested in exploring 
the distribution of cheating strains in a phylogenetic context.  Specifically, we can ask 
whether cheating strains repeatedly evolve de novo as ‘dead ends’ (i.e., similarly to 
cancer), or whether ‘professional’ cheating strains exists, which co-evolve along with 
cooperating lineages and function more as an obligate parasite (or potentially as 
mutualists; for instance in (Hammerschmidt et al., 2014), where the authors suggest 
that cheating strains may actually facilitate division of labor and thereby serve a 
beneficial function to the overall population). 
It would be of interest to see if the frequency of persisters in a population is 
evolutionarily labile in a similar manner to biofilm formation, as they are functionally 
equivalent to the biofilm cells in the model presented in Chapter 2.  However, given 
the difficulty of studying persister cells in the lab, this may be difficult to achieve 
without better understanding the causes of their formation.  Persisters have been 
thought to function as a bet hedge against antibiotic treatment (ref? not consistent 
with metabolic noise hypothesis… not sure if actually adaptive), similarly to the 
minimal levels of biofilm investment maintained by populations in Chapter 2; it 
would be interesting to evolve cells in a randomly varying environment (e.g. in 
antibiotic concentration) and monitor whether persister fraction adaptively evolves. 
In conclusion, the results presented in this thesis indicate consideration of 
heterogeneous phenotypes will be an important factor in the design of 
comprehensive antibiotic control strategies.  Our findings suggest biofilms are a 
prime target, given their virtual ubiquity, intrinsic phenotypic resistance, and 
adaptive responsiveness to antibiotic treatment.  One promising avenue to address 
this is the co-administration of ‘antibiotic adjuvants’ (Gill et al., 2014) which disrupt 
biofilm function and therefore render populations more sensitive to antibiotic 
clearance, e.g. by degrading key components of the biofilm matrix (Alipour et al., 
111 
 
2009).  Other possible routes would be to reduce the frequency of biofilm 
transmission within e.g. a hospital environment, thereby potentially imposing trade-
offs between transmission and survival.  However, a better understanding of 
microbial life histories in general will be of crucial importance to designing control 
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Table of natural and clinical isolates of P. aeruginosa used in Chapters 2 and 5. 
ID Location Country Date Source 
1 Paris France 1882-1918 Surgical bandage 
2 Paris France 1882-1918 Wound 
3 Paris France 1882-1918 Wound 
5 Paris France 1882-1918 Wound 
7 Paris France 1882-1918 Wound 
9 Paris France 1882-1918 Leg ulcer 
11 Paris France 1882-1918 Wound 
13 Paris France 1882-1918 Wound 
14 Paris France 1882-1918 Rabbit 
15 Bucarest Romania 1965-1978 Faeces 
23 Loltun Mexico 2004 Cenote water 
24 North Sea Belgium 2007 Sea water (coastal) 
26 Vancouver Canada 2002 CF-patient 
27 Ghent Belgium 2003 Shallow pond water 
28 Geel Belgium 2004 Clinical non CF 
29 Cambridge UK pre 1936 Plant 
30 Hanover Germany 1994 CF-patient 
32 Tbilisi Georgian Republic 1975 Pleural fluid 
33 Tbilisi Georgian Republic Unknown Wound 
34 Ghent Belgium 1999 Sputum 
35 Ghent Belgium 1992 Wound 
37 Ghent Belgium 1998 Urine 
38 Brussels Belgium 1993 Clinical non CF 
39 Leuven Belgium 2004 Clinical non CF 
40 Leuven Belgium 2004 Clinical non CF 
41 De Haan Belgium 1993 CF-patient 
42 De Haan Belgium 1993 CF-patient 
45 Vancouver Canada 2002 CF-patient 
47 Melbourne Australia 1955 Wound 
48 Brussels Belgium 1985 Urine 
49 Buenos Aires Argentina pre 1984 Wound 
50 Boston USA 1971 Blood 
51 Cali Colombia 2003 Blood 
52 Cali Colombia 2003 Hospital environment 
55 Unknown India Unknown Dog 
66 Unknown UK 2004 Dog 
69 Unknown UK 2004 Dog 
71 Unknown UK 2004 Dog 
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73 Unknown UK 2004 Dog 
75 Unknown UK 2004 Dog 
76 Detroit USA 1921 Unknown 
78 London UK 1924 Ear 
79 London UK 1923 Wound 
80 London UK 1937 Urine 
81 Elstree UK 1944 Urine 
82 Elstree UK 1944 Urine 
84 California USA 1949 Unknown 
86 London UK 1950 Urine 
89 Unknown The Philippines 1925 Tobacco plant 
90 Colindale UK 1962 Faeces 
92 London UK 1969 Human 
93 Surrey UK 1967 Sputum 
94 Kentucky USA 1982 Unknown 
100 Mediterranean Sea Tunisia 2000 Sea water (coastal) 
101 Istanbul Turkey 1997 Burn 
109 Jekyll Island USA 2004 Turtle egg (interior) 
111 Jekyll Island USA 2005 Turtle egg (interior) 
113 Jekyll Island USA 2005 Turtle egg (exterior) 
115 Jekyll Island USA 2005 Turtle egg (exterior) 
116 Jekyll Island USA 2006 Turtle egg (exterior) 
119 
Suruga Bay (N2, 
200m) 
Japan 2004 Sea water (coastal) 
120 
Suruga Bay (N2, 
200m) 
Japan 2004 Sea water (coastal) 
121 
Pacific Ocean (N7, 
200m) 
Japan 2004 Sea water (open ocean) 
122 
Pacific Ocean (N7, 
0m) 
Japan 2004 Sea water (open ocean) 
123 Pacific Ocean (S2, 0m) Japan 2004 Sea water (open ocean) 
124 Pacific Ocean (S2, 0m) Japan 2004 Sea water (open ocean) 
125 Sagami Bay Japan 2003 Sea water (coastal) 
126 Pacific Ocean (S2, 0m) Japan 2004 Sea water (coastal) 
127 Sagami Bay (S1, 0m) Japan 2004 Sea water (coastal) 
128 Otshuchi Bay Japan 2004 Dolphin 
129 Pacific Ocean (S2, 0m) Japan 2003 Sea water (coastal) 
130 Pacific Ocean (S2, 0m) Japan 2003 Sea water (open ocean) 
131 Pacific Ocean (S2, 0m) Japan 2003 Sea water (open ocean) 
132 Pacific Ocean (S2, 0m) Japan 2003 Sea water (open ocean) 
133 Pacific Ocean (S2, 0m) Japan 2003 Sea water (open ocean) 
134 Pacific Ocean (S4, 0m) Japan 2003 Sea water (open ocean) 
135 Arakawa river Japan 2003 River water 
136 Arakawa river Japan 2003 River water 
137 Zenpukujii pond Japan 2003 Pond water 
138 Lake Tamako Japan 2003 Lake water 
139 Lake Tamako Japan 2003 Lake water 
140 Porto Alto Portugal 2003 Horse vagina 
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141 Almada Portugal 2004 Cat nose 
142 Lisbon Portugal 2005 
Dog subcutaneous 
abcess 
143 Santarém Portugal 2006 Goat brain 
144 Glória do Ribatejo Portugal 2007 Parrot nose 
146 Lisbon Portugal 2005 Dog ear 
147 Santarém Portugal 2007 Cow milk 
148 Lisbon Portugal 2005 Dog skin 
149 Lisbon Portugal 2003 Seal organs 
150 Lisbon Portugal 2003 Dog mucosa 
151 Lisbon Portugal 2003 Dog eye 
152 Lisbon Portugal 2007 Dog eye 
153 Lisbon Portugal 2005 Dog ear 
154 Lisbon Portugal 2006 Dog pleural fluid 
155 Lisbon Portugal 2005 Parrot eye 
156 Estoril Portugal 2007 Horse uterus 
157 Amadora Portugal 2007 Turtle shell 
158 Lisbon Portugal 2006 Dog eye 
159 Famöes Portugal 2003 Cat vagina 
160 Glória do Ribatejo Portugal 2007 Parrot nose 
162 Lisbon Portugal 2006 Dog eye 
165 Alcobaça Portugal 2005 Dog ear 
167 Lisbon Portugal 2006 Kangaroo blood 
168 Lisbon Portugal 2007 Dog eye 
169 Santarém Portugal 2004 Cow milk 
170 Santo António Portugal 2005 Dog ear 
171 Porto Alto Portugal 2004 Horse uterus 
172 Lisbon Portugal 2007 Dog uterus 
174 Algarve Portugal 2004 Dolphin skin Lesion 
175 Algarve Portugal 2004 Dolphin respiratory tract 
176 Ghent Belgium 2003 CF-patient 
177 Antwerp Belgium 2003 CF-patient 
178 Antwerp Belgium 2003 CF-patient 
180 Leuven Belgium 2003 CF-patient 
183 Brussels Belgium 2003 CF-patient 
185 Brussels Belgium 2003 CF-patient 
186 Leuven Belgium 2003 CF-patient 
187 Brussels Belgium 2003 CF-patient 
189 Brussels Belgium 2003 CF-patient 
191 Ghent Belgium 2003 CF-patient 
192 Ghent Belgium 2003 CF-patient 
193 Brussels Belgium 2003 CF-patient 
195 Birmingham UK 2003 CF-patient 
196 Liverpool UK 2003 CF-patient 
197 Manchester UK 2003 CF-patient 
198 Australia Australia 1999 CF-patient 
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200 Hobart Australia 2003 Lung carcinoma 
203 Hobart Australia 2003 Sputum 
209 Hobart Australia 2005 Hospital environment 




Australia 2005 River water 
213 Hobart Australia 2004 Urine 
217 Hobart Australia 2003 CF-patient 
218 Hobart Australia 2003 CF-patient 
226 Panama City Panama 2006 Wound 
229 Woluwe river Belgium 2002 River water 
230 Woluwe river Belgium 2002 River water 
231 Woluwe river Belgium 2002 River water 
232 Woluwe river Belgium 2001 River water 
233 Woluwe river Belgium 2001 River water 
234 Woluwe river Belgium 2002 River water 
235 Woluwe river Belgium 2002 River water 
236 Woluwe river Belgium 2002 River water 
237 Woluwe river Belgium 2002 River water 
248 Brussels Belgium 1997 Hospital environment 
252 Brussels Belgium 1997 Hospital environment 
253 Brussels Belgium 1997 Plant rhizosphere 
254 Brussels Belgium 1997 Tap water room BWC 
255 Brussels Belgium 1998 Hospital environment 
257 Brussels Belgium 1998 Burn 
259 Brussels Belgium 1998 Sputum 
260 Brussels Belgium 1998 Burn 
261 Brussels Belgium 1998 Burn 
262 Brussels Belgium 1998 Burn 
263 Brussels Belgium 1998 Wound 
264 Brussels Belgium 1998 Burn 
266 Brussels Belgium 1998 
Tap water operating 
theatre 
267 Brussels Belgium 1998 Throat 
268 Brussels Belgium 1998 Wound 
269 Brussels Belgium 1999 Nose 
270 Brussels Belgium 1999 Throat 
271 Lisbon Portugal 1997 CF-patient 
272 Lisbon Portugal 1997 CF-patient 
275 Lisbon Portugal 1998 Burn 
276 London UK 1996 Burn 
277 London UK 1996 Burn 
280 London UK 1996 Wound 
292 Ann Arbor USA 1997 Burn 
293 Ann Arbor USA 1997 Pressure sore 
294 Ann Arbor USA 1997 Burn 
298 Aachen Germany 1997 Burn 
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300 San Antonio USA 1988 Wound 
304 San Antonio USA 1991 Urine 
305 San Antonio USA 1993 Urine 
307 San Antonio USA 1993 Sputum 
308 San Antonio USA 1993 Burn 
310 San Antonio USA 1996 Sputum 
311 Boston USA 1992 Burn 
312 Boston USA 1992 Burn 
313 Boston USA 1997 Burn 
314 Boston USA 1997 Blood 
315 Karachi Pakistan 1998 River water 
316 Karachi Pakistan 1998 River water 
317 Brussels Belgium 1999 Sputum 
320 Hannover Germany 1985 CF-patient 
322 Hannover Germany 1989 Hospital environment 
324 Hannover Germany 1988 CF-patient 
325 Cotonu Benin 2008 River water 
327 Bucarest Romania 1960-64 Water 
329 Canas Puerto Rico 1938 Shallow well water 
330 Unknown Puerto Rico 1961 Chinese evergreen 
331 Lwiro Congo 2001 Blood 
333 Tacloban City The Philippines 1993 Wound 
334 Mülheim Germany 1986 Drinking water 
335 Ruhr river Germany 1992 River water 
336 Mülheim Germany 1992 Swimming pool water 
337 Tunis Tunisia 1998 Ear 
338 Tunis Tunisia 1998 Sputum 
340 King City, Ontario Canada 2004 soil 
341 Unknown Canada 2004 soil 
342 King City, Ontario Canada 7/4/2010 soil 
343 King City, Ontario Canada 7/4/2010 soil 
344 King City, Ontario Canada 7/4/2010 soil 
345 Toronto Canada 8/4/2010 soil/water 
346 Maysville, KY USA 8/4/2010 soil 
347 Maysville, KY USA 8/4/2010 soil 
348 Maysville, KY USA 8/4/2010 soil/water 
349 no data South Africa 2006 golf course pond 












353 Ottawa Canada February 2006 CF-patient 




355 Hamilton Canada May 2008 CF-patient 
356 Kitchener Canada January 2006 CF-patient 
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358 Sudbury Canada January 2006 CF-patient 
359 Toronto Canada January 2006 CF-patient 
360 Hamilton Canada January 2006 CF-patient 
361 Toronto Canada January 2006 CF-patient 
362 Toronto Canada May 2006 CF-patient 
363 Hamilton Canada March 2006 CF-patient 
364 Toronto Canada April 2006 CF-patient 
365 Hamilton Canada March 2006 CF-patient 
366 Hamilton Canada April 2006 CF-patient 
367 London Canada May 2006 CF-patient 
368 London Canada June 2006 CF-patient 
369 London Canada January 2008 CF-patient 




371 Toronto Canada January 2008 CF-patient 




373 Toronto Canada October 2006 CF-patient 
374 Unknown Korea Unknown Unknown 
 
